<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Med</journal-id>
<journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id>
<journal-id journal-id-type="publisher-id">jcm</journal-id>
<journal-title-group>
<journal-title>Journal of Clinical Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2077-0383</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30544486</article-id>
<article-id pub-id-type="pmc">6306769</article-id>
<article-id pub-id-type="doi">10.3390/jcm7120521</article-id>
<article-id pub-id-type="publisher-id">jcm-07-00521</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbiome—The Missing Link in the Gut-Brain Axis: Focus on Its Role in Gastrointestinal and Mental Health</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3430-9079</contrib-id>
<name>
<surname>Skonieczna-Żydecka</surname>
<given-names>Karolina</given-names>
</name>
<xref ref-type="aff" rid="af1-jcm-07-00521">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2649-5967</contrib-id>
<name>
<surname>Marlicz</surname>
<given-names>Wojciech</given-names>
</name>
<xref ref-type="aff" rid="af2-jcm-07-00521">2</xref>
<xref ref-type="corresp" rid="c1-jcm-07-00521">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Misera</surname>
<given-names>Agata</given-names>
</name>
<xref ref-type="aff" rid="af3-jcm-07-00521">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2248-489X</contrib-id>
<name>
<surname>Koulaouzidis</surname>
<given-names>Anastasios</given-names>
</name>
<xref ref-type="aff" rid="af4-jcm-07-00521">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Łoniewski</surname>
<given-names>Igor</given-names>
</name>
<xref ref-type="aff" rid="af1-jcm-07-00521">1</xref>
</contrib>
</contrib-group>
<aff id="af1-jcm-07-00521"><label>1</label>Department of Biochemistry and Human Nutrition, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland; <email>karzyd@pum.edu.pl</email> (K.S.-Z.); <email>igorloniewski@sanum.com.pl</email> (I.L.)</aff>
<aff id="af2-jcm-07-00521"><label>2</label>Department of Gastroenterology, Pomeranian Medical University, 71-252 Szczecin, Poland</aff>
<aff id="af3-jcm-07-00521"><label>3</label>Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, 13353 Berlin, Germany; <email>agata.misera@charite.de</email></aff>
<aff id="af4-jcm-07-00521"><label>4</label>Endoscopy Unit, The Royal Infirmary of Edinburgh, EH16 4SA Edinburgh, UK; <email>akoulaouzidis@hotmail.com</email></aff>
<author-notes>
<corresp id="c1-jcm-07-00521"><label>*</label>Correspondence: <email>marlicz@hotmail.com</email>; Tel.: +48-(91)-425-32-31</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2018</year>
</pub-date>
<volume>7</volume>
<issue>12</issue>
<elocation-id>521</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 by the authors.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>The central nervous system (CNS) and the human gastrointestinal (GI) tract communicate through the gut-brain axis (GBA). Such communication is bi-directional and involves neuronal, endocrine, and immunological mechanisms. There is mounting data that gut microbiota is the source of a number of neuroactive and immunocompetent substances, which shape the structure and function of brain regions involved in the control of emotions, cognition, and physical activity. Most GI diseases are associated with altered transmission within the GBA that are influenced by both genetic and environmental factors. Current treatment protocols for GI and non-GI disorders may positively or adversely affect the composition of intestinal microbiota with a diverse impact on therapeutic outcome(s). Alterations of gut microbiota have been associated with mood and depressive disorders. Moreover, mental health is frequently affected in GI and non-GI diseases. Deregulation of the GBA may constitute a grip point for the development of diagnostic tools and personalized microbiota-based therapy. For example, next generation sequencing (NGS) offers detailed analysis of microbiome footprints in patients with mental and GI disorders. Elucidating the role of stem cell–host microbiome cross talks in tissues in GBA disorders might lead to the development of next generation diagnostics and therapeutics. Psychobiotics are a new class of beneficial bacteria with documented efficacy for the treatment of GBA disorders. Novel therapies interfering with small molecules involved in adult stem cell trafficking are on the horizon.</p>
</abstract>
<kwd-group>
<kwd>gut brain axis</kwd>
<kwd>microbiota</kwd>
<kwd>functional gastrointestinal disorders</kwd>
<kwd>inflammatory bowel disease (IBD)</kwd>
<kwd>adult stem cells</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-jcm-07-00521">
<title>1. Introduction</title>
<p>Recently, a new United Nation’s (UN) Commission goals on global mental health and sustainable development has been published [<xref ref-type="bibr" rid="B1-jcm-07-00521">1</xref>]. This Commission is in line with other UN General Assembly and High-Level Meeting report and explores the issues of mental health from those with mental disorders to whole populations [<xref ref-type="bibr" rid="B2-jcm-07-00521">2</xref>]. Accordingly, good mental health is viewed as fundamental to individual’s well-being and overall health. In addition, efforts are being focused on systemic and global changes in order to align mental health across all medical specialties [<xref ref-type="bibr" rid="B3-jcm-07-00521">3</xref>,<xref ref-type="bibr" rid="B4-jcm-07-00521">4</xref>]. In the context of the previously mentioned documents, the relationship between gut microbiota and mental health seems to be very interesting.</p>
<p>Intestinal microbiota represent one of the richest ecosystems in nature. Professor Rob Knight of the University of California, San Diego [<xref ref-type="bibr" rid="B5-jcm-07-00521">5</xref>] reported that more than half of all cells in the human body are microorganisms, which are mainly bacteria as well as fungi and viruses. Until recently, the general belief was that intestinal microbes were mainly involved in digestive processes. With the advent of new molecular techniques and bioinformatics, in-depth research has unraveled the role of intestinal microbiota in a number of physiological processes [<xref ref-type="bibr" rid="B6-jcm-07-00521">6</xref>,<xref ref-type="bibr" rid="B7-jcm-07-00521">7</xref>]. The topic of global microbial diversity is so crucial and important to human health and wellbeing that scientists from Rutgers University-New Brunswick—In a recent issue of <italic>Science</italic>—Called for the creation of a global microbiota vault to protect humanity’s long-term health [<xref ref-type="bibr" rid="B8-jcm-07-00521">8</xref>].</p>
<p>The role of the gut microbiome on human health is very diverse and implicated in the pathophysiology of various diseases. Its role in metabolism and obesity development has been clearly documented [<xref ref-type="bibr" rid="B9-jcm-07-00521">9</xref>]. More recently, gut microbes have been implicated in the pathogenesis of cancer and microbial contribution in cancer treatment [<xref ref-type="bibr" rid="B10-jcm-07-00521">10</xref>]. The pathogenesis and natural history of chronic GI, non-communicable diseases e.g., non-alcoholic steatohepatitis (NASH) [<xref ref-type="bibr" rid="B11-jcm-07-00521">11</xref>], functional gastrointestinal disorders (FGIDs) [<xref ref-type="bibr" rid="B12-jcm-07-00521">12</xref>], and non-GI disorders e.g., cardiovascular disease (CVD) [<xref ref-type="bibr" rid="B13-jcm-07-00521">13</xref>] have been linked to GI tract microbes. The alterations of gut microbiota have been associated with neurodegenerative diseases as well as mood disturbance and depression [<xref ref-type="bibr" rid="B14-jcm-07-00521">14</xref>,<xref ref-type="bibr" rid="B15-jcm-07-00521">15</xref>,<xref ref-type="bibr" rid="B16-jcm-07-00521">16</xref>]. In fact, mental health alterations are frequently observed in many GI diseases [<xref ref-type="bibr" rid="B17-jcm-07-00521">17</xref>,<xref ref-type="bibr" rid="B18-jcm-07-00521">18</xref>,<xref ref-type="bibr" rid="B19-jcm-07-00521">19</xref>,<xref ref-type="bibr" rid="B20-jcm-07-00521">20</xref>].</p>
</sec>
<sec id="sec2-jcm-07-00521">
<title>2. Paradigm Changer—Rome IV Criteria and FGIDs</title>
<p>For years, FGIDs were viewed as purely functional disorders with no scientific confirmation of a clear pathogenetic mechanism. According to Rome IV criteria, the phenotype of FGIDs results from an altered transmission of nerve and biochemical signals within the gut-brain-microbiota axis with mechanisms controlled by both genetic and environmental factors [<xref ref-type="bibr" rid="B21-jcm-07-00521">21</xref>]. Additionally, few studies conducted in patients suffering from functional dyspepsia (FD) and irritable bowel syndrome (IBS) found alterations in small bowel microbiota. Zhong et al. [<xref ref-type="bibr" rid="B22-jcm-07-00521">22</xref>] showed that <italic>Actinomyces</italic>, <italic>Atopobium</italic>, <italic>Leptotrichia</italic>, <italic>Prevotella</italic>, and <italic>Veilonella</italic> counts differ between FD and control patients. The finding was preceded by an observation that, in FD patients, gut barrier integrity is impaired and expressed as lowered transepithelial resistance, diminished expression of proteins of tight junctions, and, lastly, elevated levels of mast cells, eosinophils, and interstitial lymphocytes [<xref ref-type="bibr" rid="B23-jcm-07-00521">23</xref>]. Giamarellos-Bourboulis reported a significant reduction in the diversity of small-bowel microbiota and the number of species [<xref ref-type="bibr" rid="B24-jcm-07-00521">24</xref>]. Furthermore, Martinez et al. reported that the proportion of dilated junctions and intercellular distance between enterocytes in their apical part was elevated [<xref ref-type="bibr" rid="B25-jcm-07-00521">25</xref>]. They also found that higher tryptase mRNA expression leads to overactive bowel movements and looser stool as per Bristol stool scale. Importantly, the degranulation of mast cells was found to positively affect the firing of visceral-nociceptive sensory neurons in IBS [<xref ref-type="bibr" rid="B26-jcm-07-00521">26</xref>]. According to the new ROME IV criteria, the following factors contribute to the pathogenesis of FGIDs: (i) motility disturbance, (ii) visceral hypersensitivity, (iii) altered mucosal and immune function, (iv) altered gut microbiota, and (v) altered central nervous system (CNS). All of them are also associated with the concept of the microbiota-gut-brain axis.</p>
<p>The overlap of FGIDs and CNS disorders has been discussed in a few studies. It has been demonstrated that approximately one third of IBS patients suffer from depression [<xref ref-type="bibr" rid="B27-jcm-07-00521">27</xref>]. More recently, Batmaz et al. [<xref ref-type="bibr" rid="B28-jcm-07-00521">28</xref>] reviewed patients referred either directly to psychiatric clinics or from gastroenterology wards to psychiatrists and concluded that these patients were complaining of both GI and psychiatric symptoms. Furthermore, patients of the latter group complained more frequently of constipation, abdominal pain, and bloating and were more frequently diagnosed with psychotic disorders in comparison to those directly referred to psychiatric clinics. It is estimated that psychiatric symptoms occur in at least 36.5% of FGIDs patients [<xref ref-type="bibr" rid="B17-jcm-07-00521">17</xref>]. Stasi et al. found that the highest prevalence of mental or spectrum disorders is in patients with functional constipation (60%) as compared to patients diagnosed with FD (52.4%) and/or functional bloating (47.6%). The most prevalent psychiatric disorder observed in FGIDs were the general anxiety disorder and panic diagnosis [<xref ref-type="bibr" rid="B17-jcm-07-00521">17</xref>]. Furthermore, Wilder-smith et al. [<xref ref-type="bibr" rid="B29-jcm-07-00521">29</xref>] identified both GI and CNS symptom profiles secondary to fructose or lactose ingestion.</p>
</sec>
<sec id="sec3-jcm-07-00521">
<title>3. The Emerging Role of the Microbiota-Gut-Brain Axis</title>
<p>Studies in animal models have shown that microbiota play an essential role in shaping the structure and function of the CNS [<xref ref-type="bibr" rid="B30-jcm-07-00521">30</xref>]. Using sophisticated strategies for manipulating the microbiome, researchers observed the consequences of these changes one the brain and behavior. For example, it has been found out that the thickness of the myelin sheath, the length of dendrites, and the density of dendritic spines are controlled by microbiota [<xref ref-type="bibr" rid="B31-jcm-07-00521">31</xref>,<xref ref-type="bibr" rid="B32-jcm-07-00521">32</xref>]. A recent study by Lu et al. [<xref ref-type="bibr" rid="B33-jcm-07-00521">33</xref>] conducted in humanized germ-free mice demonstrated that slow-growing mice presented skewed neuron and oligodendrocyte development as well as evident signs of neuro-inflammation. Social competences and repetitive behaviors are, at least in part, a reflection of the composition of intestinal bacteria [<xref ref-type="bibr" rid="B34-jcm-07-00521">34</xref>]. These dependencies result directly from the existence of a physical and functional connection between the human digestive tract and the CNS. This concept called the gut-brain axis (GBA) with the participation of neural and biochemical mechanisms can be exploited for the development of new therapies for mental health disorders.</p>
<p>The CNS utilizes neural and endocrine pathways to cooperate with the gut. The sympathetic part of the autonomic nervous system and the hypothalamus-pituitary-adrenal axis (HPA) co-modulate the secretion, motility, and blood flow affecting intestinal permeability and influencing various GI disorders [<xref ref-type="bibr" rid="B35-jcm-07-00521">35</xref>]. Gut neural signals are passed through the enteric nervous system (ENS) and the vagus nerve [<xref ref-type="bibr" rid="B36-jcm-07-00521">36</xref>]. Biochemical information is carried out by cytokines, chemokines, neurotransmitters, and micro-vesicles [<xref ref-type="bibr" rid="B37-jcm-07-00521">37</xref>] as well as directly by-products of gut microbiota metabolic activity, i.e., short chain fatty acids (SCFAs). Eventually, once in the circulation, these molecules influence HPA and GBA [<xref ref-type="bibr" rid="B38-jcm-07-00521">38</xref>]. An elevated stress response may impair the psychosomatic well-being [<xref ref-type="bibr" rid="B39-jcm-07-00521">39</xref>]. With pioneering work, Sudo et al. [<xref ref-type="bibr" rid="B40-jcm-07-00521">40</xref>] demonstrated that gut microbiota is essential to proper stress hormones release and the restoration of intestinal ecosystem may reverse abnormal stress response. More recently, in vivo experimentation has demonstrated that stress mediators and their receptors’ expression are reduced in pathogen-free animals [<xref ref-type="bibr" rid="B41-jcm-07-00521">41</xref>].</p>
</sec>
<sec id="sec4-jcm-07-00521">
<title>4. How the Gut/Brain Talks to the Brain/Gut</title>
<p>Intestinal microbiota as an integral part of the intestinal barrier controls the transport of antigens through the peri-cellular route to the <italic>lamina propria</italic> where the gut associated lymphoid tissue (GALT) is located [<xref ref-type="bibr" rid="B42-jcm-07-00521">42</xref>]. The composition of intestinal microbiota can, therefore, influence intestinal barrier permeability, which guarantees the flow of molecules through the peri-cellular route to blood vessels. Gut microbes permanently train GALT to create immunity against commensal bacteria and food antigens but also to provide defense against pathogenic microorganisms [<xref ref-type="bibr" rid="B43-jcm-07-00521">43</xref>]. During dysbiosis, due to GALT activation, effector cells and inflammatory mediators disrupt gut barrier integrity and result in elevated intestinal permeability [<xref ref-type="bibr" rid="B44-jcm-07-00521">44</xref>]. The interaction of the intestinal barrier elements, thus, provides a physiologic and selective ability to absorb and secrete specific substances while inhibiting the translocation of microorganisms and the penetration of toxins and other harmful antigens [<xref ref-type="bibr" rid="B45-jcm-07-00521">45</xref>,<xref ref-type="bibr" rid="B46-jcm-07-00521">46</xref>].</p>
<p>The effects of increased intestinal permeability may manifest locally—In the GI tract—As well as extra-intestinally. For example, the concentration of zonulin—A protein that activates the intracellular signaling pathway leading to tight junctions [<xref ref-type="bibr" rid="B47-jcm-07-00521">47</xref>] modulation and a marker of intestinal permeability increases in people with inflammatory and autoimmune diseases [<xref ref-type="bibr" rid="B48-jcm-07-00521">48</xref>]. Of importance, the gut barrier resembles in structure and function the blood brain barrier (BBB) [<xref ref-type="bibr" rid="B49-jcm-07-00521">49</xref>]. Both barriers are composed of epithelial and endothelial cells laced with lymphatic vessels, macrophages, and cellular tight junctions. It has already been suggested that both IBS and pseudomembranous colitis [<xref ref-type="bibr" rid="B50-jcm-07-00521">50</xref>,<xref ref-type="bibr" rid="B51-jcm-07-00521">51</xref>] are consequences of microbiota and intestinal barrier dysfunctions and these entities frequently coexist with depression [<xref ref-type="bibr" rid="B52-jcm-07-00521">52</xref>,<xref ref-type="bibr" rid="B53-jcm-07-00521">53</xref>].</p>
</sec>
<sec id="sec5-jcm-07-00521">
<title>5. Microbiota-Gut-Brain Axis and Susceptibility to Neuropsychiatric and Gastrointestinal Disease and Response to Therapy</title>
<p>The structure of intestinal microbiota is strongly influenced by diet and environmental stressors such as drugs. It seems that these factors dominate over the impact of genotype on the gut flora composition [<xref ref-type="bibr" rid="B54-jcm-07-00521">54</xref>]. Consequently, it has been recognized that it may be the optimal marker of susceptibility to express certain clinical phenotypes and, thus, the response to pharmacotherapy [<xref ref-type="bibr" rid="B55-jcm-07-00521">55</xref>]. Since the concept of bidirectional signaling between the gut and the brain started to evolve, scientists have made attempts to discover microbial fingerprints in neurology and psychiatry. Emerging research suggested that gut-brain axis dysfunction may be involved in the etiology of depression and anxiety, schizophrenia, addiction, and neurodevelopmental and neurodegenerative diseases as well as age-related cognitive decline [<xref ref-type="bibr" rid="B14-jcm-07-00521">14</xref>,<xref ref-type="bibr" rid="B56-jcm-07-00521">56</xref>,<xref ref-type="bibr" rid="B57-jcm-07-00521">57</xref>,<xref ref-type="bibr" rid="B58-jcm-07-00521">58</xref>,<xref ref-type="bibr" rid="B59-jcm-07-00521">59</xref>]. Major microbiota-related alterations in particular neuropsychiatric conditions are summarized in <xref ref-type="table" rid="jcm-07-00521-t001">Table 1</xref>.</p>
<p>Nevertheless, uninterrupted stress regulation is pivotal to mental health and altered stress response has been implicated in the origin of psychiatric diseases [<xref ref-type="bibr" rid="B58-jcm-07-00521">58</xref>]. Numerous studies conducted in animals and humans have demonstrated that both acute and chronic stress interfere with intestinal barrier integrity and induce adverse alterations in intestinal microbiota composition. This has been confirmed in models of early-life [<xref ref-type="bibr" rid="B79-jcm-07-00521">79</xref>] stress and prenatal stress [<xref ref-type="bibr" rid="B80-jcm-07-00521">80</xref>]. Yarandi et al. [<xref ref-type="bibr" rid="B81-jcm-07-00521">81</xref>] showed that water and ion in the gut might be reduced and elevated, respectively, under stressful conditions. This, in turn, impairs the physical protection of the gut barrier against both pathogenic microorganisms and nociceptive molecules. Furthermore, HPA activation, in particular corticotropin-releasing factor (CRF), showed a causative role in gut integrity disruption [<xref ref-type="bibr" rid="B82-jcm-07-00521">82</xref>]. Elevated intestinal permeability was also found to be linked to stress-induced hypersensitivity of the rectum in animals, which were studied by means of partial restraint stress [<xref ref-type="bibr" rid="B83-jcm-07-00521">83</xref>]. Winter et al. merged microbiome data from both animals and humans and selected bacterial genera that were either over-represented or appeared in a reduced number following stressor exposure. The first group included: <italic>Desulfovibrio, Eggerthella, Holdemania, Turicibacter, Clostridium, Blautia</italic>, <italic>Anaerofilum</italic> and <italic>Roseburia</italic> whereas those found in reduced numbers were: <italic>Prevotella</italic>, <italic>Bacteroides</italic>, <italic>Mucispirillum</italic>, <italic>Dialister</italic>, <italic>Allobaculum</italic>, <italic>Faecalibacterium</italic>, <italic>Oscillospira</italic>, <italic>Ruminococcus</italic>, <italic>Dorea</italic>, <italic>Coprococcus</italic>, and <italic>Pseudobytyrivibrio</italic> [<xref ref-type="bibr" rid="B84-jcm-07-00521">84</xref>].</p>
<sec>
<title>Emerging New Concepts in the Development of Neurodegenerative and GI Disease—Gut Microbes, Innate Immunity, and Bone Marrow Stem Cells as Partners in Crime</title>
<p>Mood and psychiatric disorders as well as numerous GI disorders are related to chronic inflammation [<xref ref-type="bibr" rid="B85-jcm-07-00521">85</xref>]. For example, post-infectious IBS alters GI tract motility and behavior [<xref ref-type="bibr" rid="B86-jcm-07-00521">86</xref>]. A similar effect appears in patients with FD [<xref ref-type="bibr" rid="B87-jcm-07-00521">87</xref>]. Behavioral alterations predominate in chronic GI inflammatory disorders [<xref ref-type="bibr" rid="B88-jcm-07-00521">88</xref>]. Chronic inflammation of the ENS can easily affect the CNS. However, knowledge on mechanisms behind this phenomenon is still scarce. For decades, inflammation in the brain, which were recently implicated in the pathogenesis of psychiatric diseases, has been considered “sterile.” However, recent reports reveal the presence of the gut-vascular barrier (GVB), which, in structure and function, resembles the blood brain barier (BBB) and their communication is mediated via blood and bone marrow systems [<xref ref-type="bibr" rid="B89-jcm-07-00521">89</xref>]. GVB controls the dissemination of bacteria from the gut into the bloodstream and the <italic>Salmonella typhimirum</italic> infection has been shown to decrease the Wnt/β catenin-inducible gene Axin2 (a marker of stem cell renewal) in the gut endothelium.</p>
<p>Importantly, the Wnt/β catenin signaling pathway is universally involved in trafficking (mobilization and proliferation) of stem cells deposited in adult tissues [<xref ref-type="bibr" rid="B90-jcm-07-00521">90</xref>] including those located in GI tract [<xref ref-type="bibr" rid="B91-jcm-07-00521">91</xref>]. Wnt/β catenin system has also been involved in the developmental control of BBB formation [<xref ref-type="bibr" rid="B92-jcm-07-00521">92</xref>]. It has been demonstrated that various types of bone marrow-derived stem cells are mobilized into peripheral blood in patients and experimental animals in response to tissue/organ injury [<xref ref-type="bibr" rid="B93-jcm-07-00521">93</xref>]. Examples include myocardial infarction [<xref ref-type="bibr" rid="B94-jcm-07-00521">94</xref>], stroke [<xref ref-type="bibr" rid="B95-jcm-07-00521">95</xref>], deep skin burns [<xref ref-type="bibr" rid="B96-jcm-07-00521">96</xref>], and gut inflammation [<xref ref-type="bibr" rid="B97-jcm-07-00521">97</xref>]. It has been previously shown that circulating peripheral bone marrow mononuclear cells (PBMNCs) were enriched with cells expressing mRNA of leucine-rich repeat-containing G-protein coupled receptor 5 (lgr-5), Achaete-scute complex homolog 2 (Ascl-2), Doublecortin Like Kinase 1 (Dclk-1), Male-specific lethal 1 homolog (MSL1), and B lymphoma Mo-MLV insertion region 1 homolog (BML-1). These markers are involved in the development of early intestinal lineage [<xref ref-type="bibr" rid="B97-jcm-07-00521">97</xref>]. These circulating in PB cells could potentially be involved in reparatory mechanisms of peripheral tissues including the brain [<xref ref-type="bibr" rid="B98-jcm-07-00521">98</xref>].</p>
<p>In fact, the release of very small embryonic-like stem cells (VSELs) and more differentiated neural stem cells (NSCs) from bone marrow into the peripheral blood in response to brain injury in rodents [<xref ref-type="bibr" rid="B99-jcm-07-00521">99</xref>] and humans [<xref ref-type="bibr" rid="B95-jcm-07-00521">95</xref>] has been well documented. Recent research indicates the involvement of other factors such as small bioactive lipids that may direct mobilization and trafficking of stem cells to injured organs [<xref ref-type="bibr" rid="B100-jcm-07-00521">100</xref>]. Notably, release of sphingiosine-1-phosphate (S1P) correlates with the activation of the complement cascade and formation of the C5b-C9 membrane attack complex (MAC). Activation of proteolytic and fibrynolitis complement cascades. The release of cleavage fragments (e.g., C5a and desArgC5a fragments) could enhance the mobilization of stem cells from their niche in the bone marrow [<xref ref-type="bibr" rid="B101-jcm-07-00521">101</xref>]. Moreover, these stem cells can be attracted from the bone marrow and from the intestinal epithelium in response to tumor or injured tissue derived plasma chemo-atractants such as stromal derived factor-1 (SDF-1), vascular endothelial growth factor (VEGF), zonulin, hepatocyte growth factor (HGF) or shphingosine-1-phosphate (S1P), ceramides, and extracellular nucleotides [<xref ref-type="bibr" rid="B102-jcm-07-00521">102</xref>,<xref ref-type="bibr" rid="B103-jcm-07-00521">103</xref>]. On the other hand, stem cells may secrete their own growth factors, cytokines, or even membrane-derived micro-vesicles that accelerate the regeneration process [<xref ref-type="bibr" rid="B104-jcm-07-00521">104</xref>]. The previously mentioned factors have been frequently implicated in the pathogenesis of gastrointestinal and psychiatric disorders [<xref ref-type="bibr" rid="B89-jcm-07-00521">89</xref>,<xref ref-type="bibr" rid="B105-jcm-07-00521">105</xref>].</p>
<p>We envision that stem cells together with the GI microbiome are mutually involved in the pathogenesis of disorders of GBA by employing different mechanisms (e.g., autocrine, paracrine, or hormonal effects, immunomodulatory effects, replacement of damaged cells, cytotoxic effects, and neurotoxic effects) in distant tissues and organs. Further studies are needed to assess more accurately the mechanisms of cell-host-microbe interactions (<xref ref-type="fig" rid="jcm-07-00521-f001">Figure 1</xref>). Knowledge around these mechanisms already allows the design of novel treatments targeting GBA. For example, structural analog of S1P —Fingolimod and Ozanimod, functional antagonists of S1P receptors have already been applied in the treatment of relapsing forms of multiple sclerosis [<xref ref-type="bibr" rid="B106-jcm-07-00521">106</xref>] as well as ulcerative colitis [<xref ref-type="bibr" rid="B107-jcm-07-00521">107</xref>]. Similarly, supplementation with multi-species probiotics (Ecologic<sup>®</sup> Barrier, Amsterdam, The Netherlands) in a 12-week, placebo-controlled, randomized clinical study, which favorably modified both functional and biochemical markers (e.g., VEGF) of vascular dysfunction in obese postmenopausal women [<xref ref-type="bibr" rid="B108-jcm-07-00521">108</xref>].</p>
<p>Emerging scientific data show that rapid changes in diet and lifestyle significantly contribute to the weakening of old evolutionary cell door-keeping mechanisms (e.g., Wnt/β catenin system) in the gut and the brain. The notion that even minor and subclinical stimuli to the gut mucosal and vascular barrier (e.g., infection) can result in significant, though delayed, consequences that may seriously affect the health of an individual is attractive [<xref ref-type="bibr" rid="B109-jcm-07-00521">109</xref>], it still requires further detailed studies.</p>
</sec>
</sec>
<sec id="sec6-jcm-07-00521">
<title>6. Drug-Microbiome Interactions—Still Neglected Problem in Clinical Medicine</title>
<p>Although microbiota alterations play—At least in part—A role in the etiology of neuropsychiatric diseases. Paradoxically, the treatment of these conditions may adversely affect the composition of intestinal microbiota. In fact, multiple drugs were found to be involved in dysbiosis origin [<xref ref-type="bibr" rid="B110-jcm-07-00521">110</xref>,<xref ref-type="bibr" rid="B111-jcm-07-00521">111</xref>,<xref ref-type="bibr" rid="B112-jcm-07-00521">112</xref>]. Recently, Maier [<xref ref-type="bibr" rid="B113-jcm-07-00521">113</xref>] reported that approximately one-fourth of about 10,000 non-antibiotic drugs were found to be able to reduce the in vitro growth of particular bacteria strain. Among these, the psychiatric drugs were predominant. In fact, certain pharmaceuticals utilized in neurology and psychiatry, which are predominantly antidepressants and antipsychotics, were historically characterized for being antibacterial agents. Evidence gathered mostly from animal studies but also in humans suggests that second-generation antipsychotics (SGA), which are mainly olanzapine and risperidone, change the composition of intestinal bacteria toward bacterial species promoting obesity. As demonstrated by several authors, the administration of these psychotropic drugs may increase the <italic>Firmicutes</italic>/<italic>Bacteroidetes</italic> ratio [<xref ref-type="bibr" rid="B114-jcm-07-00521">114</xref>,<xref ref-type="bibr" rid="B115-jcm-07-00521">115</xref>,<xref ref-type="bibr" rid="B116-jcm-07-00521">116</xref>,<xref ref-type="bibr" rid="B117-jcm-07-00521">117</xref>,<xref ref-type="bibr" rid="B118-jcm-07-00521">118</xref>] previously found to be a microbiota profile of the obese [<xref ref-type="bibr" rid="B119-jcm-07-00521">119</xref>].</p>
<p>The majority of studies aimed to look for the link between antipsychotic-induced metabolic malfunctions and microbiota dysbiosis were in vivo models. In rats treated with olanzapine (OLZ) and mice fed with a high fat diet and administered with OLZ, the microbiome diversity was found to be reduced [<xref ref-type="bibr" rid="B115-jcm-07-00521">115</xref>,<xref ref-type="bibr" rid="B118-jcm-07-00521">118</xref>]. When treated with another neuroleptic agent, namely risperidone (RIS), fewer operational taxonomy units (OTUs) were found in female mice [<xref ref-type="bibr" rid="B117-jcm-07-00521">117</xref>]. Davey et al. demonstrated gender-dependent elevation of <italic>Firmicutes</italic> abundance and a decrease of <italic>Bacteroidetes</italic> [<xref ref-type="bibr" rid="B115-jcm-07-00521">115</xref>,<xref ref-type="bibr" rid="B116-jcm-07-00521">116</xref>]. Antipsychotic-driven dysbiosis in rodents resulted in decreased counts of beneficial <italic>Actinobacteria</italic> and <italic>Proteobacteria</italic> [<xref ref-type="bibr" rid="B115-jcm-07-00521">115</xref>]. The OLZ regimen introduced higher abundance of <italic>Erysipelotrichia</italic> and <italic>Gammaproteobacteria</italic> and lower abundance of <italic>Bacteroidia</italic>. Lastly, OLZ suppressed the growth of anaerobic bacteria [<xref ref-type="bibr" rid="B117-jcm-07-00521">117</xref>] and <italic>Escherichia coli</italic> NC101 [<xref ref-type="bibr" rid="B118-jcm-07-00521">118</xref>].</p>
<p>In parallel, very few studies in humans explored the alterations of the gut microbiome following SGA treatment. Skewed intestinal microbiota following the psychotropic pharmacotherapy in humans expressed as elevated phylogenetic diversity and evaluated by means of PcoA of unweighted UniFrac distances [<xref ref-type="bibr" rid="B120-jcm-07-00521">120</xref>] and reduced Simpson diversity in females [<xref ref-type="bibr" rid="B121-jcm-07-00521">121</xref>] have been reported. Chronic use of RIS in children elevated the levels of <italic>Clostridium</italic>, <italic>Lactobacillus</italic>, <italic>Ralstonia</italic>, and <italic>Eubacterium</italic>. This occurred only in patients with a significant gain in BMI [<xref ref-type="bibr" rid="B120-jcm-07-00521">120</xref>]. Flowers et al. conducted gut microbiota analyses in adult patients diagnosed with bipolar disorder and demonstrated that psychotropic treatment increased concentration of family <italic>Lachnospiraceae</italic> in the whole cohort of patients treated with SGA and a group of obese subjects. In addition, lowered counts of <italic>Akkermansia</italic> genera were noticed in the whole cohort of patients receiving treatment [<xref ref-type="bibr" rid="B121-jcm-07-00521">121</xref>]. Yuan et al. lowered the levels of <italic>Clostridium coccoides</italic> Kaneuchi and <italic>Lactobacillus</italic> spp. and elevated the numbers of <italic>Escherichia coli</italic> Castellani and Chalmers in adult schizophrenia patients since six weeks of RIS treatment, which demonstrated that these variations may have induced body weight gain and increased fasting plasma glucose, homeostasis model assessment of insulin resistance (HOMA-IR), and low density lipoprotein (LDL) cholesterol concentration [<xref ref-type="bibr" rid="B122-jcm-07-00521">122</xref>]. As far as metabolic disturbances are concerned, studies by Bahr et al. [<xref ref-type="bibr" rid="B120-jcm-07-00521">120</xref>] and Flowers et al. [<xref ref-type="bibr" rid="B121-jcm-07-00521">121</xref>] microbiota alteration during psychotropic treatment may correlate with weight gain.</p>
<p>We previously demonstrated that SGA-induced dysbiosis may potentially result in body weight and metabolic disturbances with low-level inflammation and decreased energy expenditure involved in the mechanism. However, since the majority of studies were conducted in rodent models with a high number of unclear risk of bias assessments, these findings need to be considered cautiously and may not be fully replicated in humans [<xref ref-type="bibr" rid="B123-jcm-07-00521">123</xref>]. More studies regarding the involvement of psychiatric medications on gut microbiota composition in humans are warranted and, ccurrently, our research team undertook this effort.</p>
<p>The first antidepressant—Iproniazid—Via producing isonicotinoyl radicals may interrupt the bacterial cell cycle and inhibit their growth [<xref ref-type="bibr" rid="B124-jcm-07-00521">124</xref>,<xref ref-type="bibr" rid="B125-jcm-07-00521">125</xref>]. Tricyclic antidepressants were found to possess anti-plasmid activity and inhibit the growth of <italic>Escherichia coli</italic> Castellani and Chalmers, <italic>Yersinia enterocolitica</italic> Schleifstein &amp; Coleman [<xref ref-type="bibr" rid="B126-jcm-07-00521">126</xref>] and <italic>Giardia lamblia</italic> Kofoid &amp; Christiansen [<xref ref-type="bibr" rid="B127-jcm-07-00521">127</xref>] by means of decreasing the activity of DNA gyrase [<xref ref-type="bibr" rid="B128-jcm-07-00521">128</xref>]. Tricyclic antidepressants are active relative to Plasmodium falciparum [<xref ref-type="bibr" rid="B129-jcm-07-00521">129</xref>] and <italic>Leishmania</italic> spp. [<xref ref-type="bibr" rid="B130-jcm-07-00521">130</xref>]. Selective serotonin re-uptake inhibitors may inhibit the growth of <italic>Staphylococcus</italic>, <italic>Enterococcus</italic> [<xref ref-type="bibr" rid="B131-jcm-07-00521">131</xref>,<xref ref-type="bibr" rid="B132-jcm-07-00521">132</xref>,<xref ref-type="bibr" rid="B133-jcm-07-00521">133</xref>], <italic>Citrobacter</italic> spp, <italic>Pseudomonas aeruginosa</italic> Migula, <italic>Klebsiella pneumoniae</italic> Trevisan, <italic>Morganella morganii</italic> Brenner et al., <italic>Clostridium perfringens</italic> Hauduroy et al., and <italic>Clostridium difficile</italic> Prevot [<xref ref-type="bibr" rid="B131-jcm-07-00521">131</xref>,<xref ref-type="bibr" rid="B134-jcm-07-00521">134</xref>]. Efflux pump inhibition may be involved in these properties [<xref ref-type="bibr" rid="B135-jcm-07-00521">135</xref>]. Ketamine may control the growth of <italic>Staphylococcus aureus</italic> Rosenbach, <italic>Staphylococcus epidermidis</italic> Evans, <italic>Entercoccus faecalis</italic> Schleifer and Kilpper-Bälz, <italic>Streptococcus pyogenes</italic> Rosenbach, <italic>Pseudomonas aeruginosa</italic> Migula and <italic>Candida albicans</italic> (C.P.Robin) Berkhout [<xref ref-type="bibr" rid="B134-jcm-07-00521">134</xref>,<xref ref-type="bibr" rid="B136-jcm-07-00521">136</xref>].</p>
</sec>
<sec id="sec7-jcm-07-00521">
<title>7. Modulation of Microbiota-Gut-Brain Axis as a Promising Tool to Manage Gastrointestinal and Mental Health</title>
<p>Mood disorders and depression are associated frequently with other GI conditions such as liver disease, inflammatory bowel disease (IBD), food intolerance, enteropathies (e.g., celiac disease), and cancer. Recently, Felice and O’Mahony [<xref ref-type="bibr" rid="B137-jcm-07-00521">137</xref>] explained the origin of the high coincidence between stress-related psychiatric conditions and GI symptoms. Dysbiotic gut microbiota via synthesizing neuroactive metabolites are able to counteract secretion, motility, and blood flow within the GI tract and, additionally, transfer neural signals through vagus nerve and spinal cord routes. Therefore, the modulation of microbiota-gut-brain pathways opens up new avenues for the management of chronic diseases both of psychiatric and organic origin [<xref ref-type="bibr" rid="B12-jcm-07-00521">12</xref>,<xref ref-type="bibr" rid="B138-jcm-07-00521">138</xref>,<xref ref-type="bibr" rid="B139-jcm-07-00521">139</xref>,<xref ref-type="bibr" rid="B140-jcm-07-00521">140</xref>,<xref ref-type="bibr" rid="B141-jcm-07-00521">141</xref>,<xref ref-type="bibr" rid="B142-jcm-07-00521">142</xref>,<xref ref-type="bibr" rid="B143-jcm-07-00521">143</xref>].</p>
<p>The new treatment avenues could be addressed through the modulation of the microbiota-gut-brain axis by means of prebiotic and probiotic administration. The World Gastroenterology Organization (WGO) recently issued a Global Guideline on Prebiotics and Probiotics use by healthcare professionals [<xref ref-type="bibr" rid="B144-jcm-07-00521">144</xref>]. Among probiotics, those are recommended in the management of disorders of gut-brain interaction commonly known as FGIDs: <italic>Lactobacillus plantarum</italic> Bergey et al. 299V, <italic>Bifidobacterium infantis</italic> Reuter 35624, <italic>Bifidobacterium animalis</italic> Scardovi and Trovatelli DN-173 010, and <italic>Saccharomyces boullardii</italic> Henri Boulard CNCM I-745.</p>
<sec>
<title>Psychobiotics—New Kid on the Block</title>
<p>Psychobiotics are a new class of probiotics which, when ingested, confer mental health benefits through interactions with the microbiota-gut-brain axis [<xref ref-type="bibr" rid="B145-jcm-07-00521">145</xref>]. This term should also include prebiotics, which favorably influence the growth of beneficial gut bacteria [<xref ref-type="bibr" rid="B146-jcm-07-00521">146</xref>]. Some of the properties of probiotics are prevalent among different strains, e.g., improvement of the intestinal epithelium renewal while the others are strain-specific, e.g., modulation of the CNS function [<xref ref-type="bibr" rid="B147-jcm-07-00521">147</xref>]. Misra et al. noted that psychobiotic strains may be involved in the neuroactive substances synthesis, activate directly neural pathways, modulate neurotrophic factors, protect microbiota against stress, and others [<xref ref-type="bibr" rid="B148-jcm-07-00521">148</xref>].</p>
<p>The action of psychobiotics was confirmed in mechanistic studies. For example, Ait-Belgnaoui et al. [<xref ref-type="bibr" rid="B149-jcm-07-00521">149</xref>] demonstrated that psychobiotics may significantly reduce stress-induced neuronal activation in three brain regions i.e., hypothalamus, amygdala, and hippocampus, and promote the development of dendrites in the cingulate cortex-center of neurogenesis. Another study confirmed that psychobiotics decreased visceral hypersensitivity intensity and such an action correlated with the concentration of stress hormones (noradrenaline, adrenaline, corticosterone) and was possibly regulated by glucocorticoid receptors [<xref ref-type="bibr" rid="B150-jcm-07-00521">150</xref>]. In vivo studies also reported that ingestion of psychobiotics improved GI function through the modulation of GBA in animals experiencing maternal separation [<xref ref-type="bibr" rid="B151-jcm-07-00521">151</xref>] and <italic>Citrobacter rodentium</italic> infection [<xref ref-type="bibr" rid="B152-jcm-07-00521">152</xref>].</p>
<p>Lately, the importance of psychobiotic use in humans has been acknowledged. Diop et al. was the first to demonstrate that probiotic supplementation reduces symptoms of GI disorders caused by stress in healthy people [<xref ref-type="bibr" rid="B153-jcm-07-00521">153</xref>]. Messaoudi et al. showed that psychobiotic strains impact positively psychological stress exponents and reduce urinary free cortisol concentration [<xref ref-type="bibr" rid="B154-jcm-07-00521">154</xref>]. Steenbergen et al. [<xref ref-type="bibr" rid="B155-jcm-07-00521">155</xref>] demonstrated that, after 4 weeks of probiotic supplementation, a statistically significant improvement of aggression and rumination compared to placebo was found. Allen et al. [<xref ref-type="bibr" rid="B156-jcm-07-00521">156</xref>] tested the psychobiotic strain to find that it may improve memory and reduce stress while Kato-Katoka [<xref ref-type="bibr" rid="B157-jcm-07-00521">157</xref>] who analyzed a group of students during the exam session reported that the incidence of abdominal pain and cold as vegetative stress symptoms was significantly lowered in the group of students receiving probiotics compared to the placebo group. A recent study by Lv et al. [<xref ref-type="bibr" rid="B158-jcm-07-00521">158</xref>] summarized that psychobiotics improve the function of the GI tract in patients with schizophrenia.</p>
<p>In addition, meta-analyses have shown that probiotic intervention may positively affect the mood in healthy persons as well as depressive patients [<xref ref-type="bibr" rid="B159-jcm-07-00521">159</xref>]. McKean et al. [<xref ref-type="bibr" rid="B160-jcm-07-00521">160</xref>] found that probiotic consumption may diminish the symptoms of depression, anxiety, and stress. Surprisingly, the latest meta-analysis concluded that such an intervention may significantly improve the mood of patients with mild to moderate depression but not the mood of healthy individuals [<xref ref-type="bibr" rid="B161-jcm-07-00521">161</xref>]. Consequently, psychobiotics and neurobiotics, which are capable of GBA and HPA modulation, could be advocated in the management of patients endangered with iatrogenic complications associated with pharmacotherapy and polypharmacy. However, more studies—Especially of the highest evidence level—Are necessary to elucidate the psychobiotic potential to improve GBA function.</p>
<p>The use of these new probiotic compounds could be of great use in the daily management of stress and depression in FGIDs patients but also with other GI and extra-intestinal complaints associated with mental or mood alterations [<xref ref-type="bibr" rid="B162-jcm-07-00521">162</xref>,<xref ref-type="bibr" rid="B163-jcm-07-00521">163</xref>]. The data supporting their use are already strong and new studies that shall create even more evidence to medical societies as well as governmental agencies to help them evaluate the microbiota-gut-brain axis therapeutics in the management of stress in contemporary medicine [<xref ref-type="bibr" rid="B164-jcm-07-00521">164</xref>,<xref ref-type="bibr" rid="B165-jcm-07-00521">165</xref>]. <xref ref-type="table" rid="jcm-07-00521-t002">Table 2</xref> includes examples of psychobiotic strains and their clinical applications [<xref ref-type="bibr" rid="B144-jcm-07-00521">144</xref>,<xref ref-type="bibr" rid="B148-jcm-07-00521">148</xref>,<xref ref-type="bibr" rid="B166-jcm-07-00521">166</xref>]. Since a few probiotic strains were found to be effective to counteract mood disorders and FGIDs, there is still limited data in individuals with ASD, Parkinson’s disease, and Alzheimer’s disease. There is an urgent need for a great investment in clinical trials in these entities [<xref ref-type="bibr" rid="B167-jcm-07-00521">167</xref>,<xref ref-type="bibr" rid="B168-jcm-07-00521">168</xref>,<xref ref-type="bibr" rid="B169-jcm-07-00521">169</xref>,<xref ref-type="bibr" rid="B170-jcm-07-00521">170</xref>,<xref ref-type="bibr" rid="B171-jcm-07-00521">171</xref>].</p>
</sec>
</sec>
<sec id="sec8-jcm-07-00521">
<title>8. Conclusions</title>
<p>Our review suggests some involvements of GBA deregulation in the origin of disorders of the brain and gut. We hypothesize that stem cell-host microbiome cross talk is potentially involved in GBA disorders. Consequently, molecules mediating GBA signaling may constitute a grip point for the development of diagnostic tools and personalized microbiota-based therapies. In addition, novel treatment protocols based on new compounds interfering with gut derived metabolites as well as small molecules and bioactive lipids playing roles in adult stem cell trafficking are awaiting further developments.</p>
</sec>
</body>
<back>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, K.S.-Ż., W.M., I.Ł. Investigation, all. Writing—Original Draft Preparation, K.S.-Ż. Writing—Review, editing, final approval, all. Supervision, W.M. and I.Ł.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research received no external funding.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>Igor Łoniewski and Wojciech Marlicz are cofounders and shareholders in the Sanprobi-probiotic manufacturer and marketing company. Karolina Skonieczna-Żydecka received remunerations for speaking engagements from Sanprobi. The content of this study was neither influenced nor constrained by these facts. The other authors have no conflicts of interest to declare.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-jcm-07-00521">
<label>1.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<article-title>Mental Health Included in the UN Sustainable Development Goals</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mental_health/SDGs/en/">http://www.who.int/mental_health/SDGs/en/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-11-25">(accessed on 25 November 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B2-jcm-07-00521">
<label>2.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<article-title>Third United Nations High-level Meeting on NCDs</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/ncds/governance/third-un-meeting/en/">http://www.who.int/ncds/governance/third-un-meeting/en/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-11-25">(accessed on 25 November 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B3-jcm-07-00521">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Chand</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Towards a new era for mental health</article-title>
<source/>Lancet
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/S0140-6736(18)32272-4</pub-id>
</element-citation>
</ref>
<ref id="B4-jcm-07-00521">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thornicroft</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Baingana</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chisholm</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>P.Y.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Lancet Commission on global mental health and sustainable development</article-title>
<source/>Lancet
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/S0140-6736(18)31612-X</pub-id>
</element-citation>
</ref>
<ref id="B5-jcm-07-00521">
<label>5.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Gallagher</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>More than Half Your Body is not Human</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.bbc.com/news/health-43674270">https://www.bbc.com/news/health-43674270</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-12-06">(accessed on 6 December 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B6-jcm-07-00521">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>The Human Intestinal Microbiome in Health and Disease</article-title>
<source/>N. Engl. J. Med.
          <year>2016</year>
<volume>375</volume>
<fpage>2369</fpage>
<lpage>2379</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra1600266</pub-id>
<pub-id pub-id-type="pmid">27974040</pub-id>
</element-citation>
</ref>
<ref id="B7-jcm-07-00521">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloomfield</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Rook</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stanwell-Smith</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Time to abandon the hygiene hypothesis: New perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene</article-title>
<source/>Perspect. Public Health
          <year>2016</year>
<volume>136</volume>
<fpage>213</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1177/1757913916650225</pub-id>
<pub-id pub-id-type="pmid">27354505</pub-id>
</element-citation>
</ref>
<ref id="B8-jcm-07-00521">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bello</surname>
<given-names>M.G.D.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Preserving microbial diversity</article-title>
<source/>Science
          <year>2018</year>
<volume>362</volume>
<fpage>33</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1126/science.aau8816</pub-id>
<pub-id pub-id-type="pmid">30287652</pub-id>
</element-citation>
</ref>
<ref id="B9-jcm-07-00521">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bretin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gewirtz</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Chassaing</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Microbiota and metabolism: What’s new in 2018?</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2018</year>
<volume>315</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00014.2018</pub-id>
<pub-id pub-id-type="pmid">29486139</pub-id>
</element-citation>
</ref>
<ref id="B10-jcm-07-00521">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rea</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Palma</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Barbieri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Luciano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Del Prete</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rossetti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Berretta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Facchini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Perdonà</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota effects on cancer: From risks to therapies</article-title>
<source/>Oncotarget
          <year>2018</year>
<volume>9</volume>
<fpage>17915</fpage>
<lpage>17927</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.24681</pub-id>
<pub-id pub-id-type="pmid">29707157</pub-id>
</element-citation>
</ref>
<ref id="B11-jcm-07-00521">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schnabl</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Gut microbiota, fatty liver disease, and hepatocellular carcinoma</article-title>
<source/>Liver Res.
          <year>2018</year>
<volume>2</volume>
<fpage>43</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1016/j.livres.2017.11.005</pub-id>
<pub-id pub-id-type="pmid">30416839</pub-id>
</element-citation>
</ref>
<ref id="B12-jcm-07-00521">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Skonieczna-Żydecka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Loniewski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>van Hemert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Loniewska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Koulaouzidis</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>From clinical uncertainties to precision medicine: The emerging role of the gut barrier and microbiome in small bowel functional diseases</article-title>
<source/>Expert Rev. Gastroenterol. Hepatol.
          <year>2017</year>
<volume>11</volume>
<fpage>961</fpage>
<lpage>978</lpage>
<pub-id pub-id-type="doi">10.1080/17474124.2017.1343664</pub-id>
<pub-id pub-id-type="pmid">28618973</pub-id>
</element-citation>
</ref>
<ref id="B13-jcm-07-00521">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanduzzi Zamparelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Compare</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Coccoli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rocco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nardone</surname>
<given-names>O.M.</given-names>
</name>
<name>
<surname>Marrone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gasbarrini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grieco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nardone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Miele</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease</article-title>
<source/>Int. J. Mol. Sci.
          <year>2016</year>
<volume>17</volume>
<elocation-id>1225</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms17081225</pub-id>
</element-citation>
</ref>
<ref id="B14-jcm-07-00521">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skonieczna-Żydecka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Łoniewski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Maciejewska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Mikrobiota jelitowa iskładniki pokarmowe jako determinanty funkcji układu nerwowego. Część I. Mikrobiota przewodu pokarmowego</article-title>
<source/>Aktualności Neurologiczne
          <year>2017</year>
<volume>17</volume>
<fpage>181</fpage>
<lpage>188</lpage>
<comment>(In Polish)</comment>
<pub-id pub-id-type="doi">10.15557/AN.2017.0020</pub-id>
</element-citation>
</ref>
<ref id="B15-jcm-07-00521">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cenit</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Codoñer-Franch</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Influence of gut microbiota on neuropsychiatric disorders</article-title>
<source/>World J. Gastroenterol.
          <year>2017</year>
<volume>23</volume>
<fpage>5486</fpage>
<lpage>5498</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v23.i30.5486</pub-id>
<pub-id pub-id-type="pmid">28852308</pub-id>
</element-citation>
</ref>
<ref id="B16-jcm-07-00521">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marizzoni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Provasi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cattaneo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frisoni</surname>
<given-names>G.B.</given-names>
</name>
</person-group>
<article-title>Microbiota and neurodegenerative diseases</article-title>
<source/>Curr. Opin. Neurol.
          <year>2017</year>
<volume>30</volume>
<fpage>630</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0000000000000496</pub-id>
<pub-id pub-id-type="pmid">28906270</pub-id>
</element-citation>
</ref>
<ref id="B17-jcm-07-00521">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stasi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nisita</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cortopassi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Corretti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gambaccini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Bortoli</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fani</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Simonetti</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ricchiuti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dell’Osso</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthreshold psychiatric psychopathology in functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry?</article-title>
<source/>Gastroenterol. Res. Pract.
          <year>2017</year>
<volume>2017</volume>
<pub-id pub-id-type="doi">10.1155/2017/1953435</pub-id>
</element-citation>
</ref>
<ref id="B18-jcm-07-00521">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernstein</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Hitchon</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Walld</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Sareen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Graff</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Patten</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lix</surname>
<given-names>L.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased burden of psychiatric disorders in inflammatory bowel disease</article-title>
<source/>Inflamm. Bowel Dis.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1093/ibd/izy235</pub-id>
</element-citation>
</ref>
<ref id="B19-jcm-07-00521">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Sawadjaan</surname>
<given-names>F.L.B.</given-names>
</name>
<name>
<surname>Isaac</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Chuah</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability</article-title>
<source/>Dig. Liver Dis.
          <year>2017</year>
<volume>49</volume>
<fpage>1314</fpage>
<lpage>1319</lpage>
<pub-id pub-id-type="doi">10.1016/j.dld.2017.08.020</pub-id>
<pub-id pub-id-type="pmid">28882540</pub-id>
</element-citation>
</ref>
<ref id="B20-jcm-07-00521">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frolkis</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Vallerand</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Shaheen</surname>
<given-names>A.-A.</given-names>
</name>
<name>
<surname>Lowerison</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Swain</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Barnabe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Patten</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>G.G.</given-names>
</name>
</person-group>
<article-title>Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression</article-title>
<source/>Gut
          <year>2018</year>
<pub-id pub-id-type="doi">10.1136/gutjnl-2018-317182</pub-id>
</element-citation>
</ref>
<ref id="B21-jcm-07-00521">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drossman</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Hasler</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Rome IV-functional GI disorders: Disorders of gut-brain interaction</article-title>
<source/>Gastroenterology
          <year>2016</year>
<volume>150</volume>
<fpage>1257</fpage>
<lpage>1261</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2016.03.035</pub-id>
<pub-id pub-id-type="pmid">27147121</pub-id>
</element-citation>
</ref>
<ref id="B22-jcm-07-00521">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koloski</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Talley</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Holtmann</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Dyspepsia and the microbiome: Time to focus on the small intestine</article-title>
<source/>Gut
          <year>2017</year>
<volume>66</volume>
<fpage>1168</fpage>
<lpage>1169</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2016-312574</pub-id>
<pub-id pub-id-type="pmid">27489239</pub-id>
</element-citation>
</ref>
<ref id="B23-jcm-07-00521">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanheel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vicario</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vanuytsel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Van Oudenhove</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Keita</surname>
<given-names>Å.V.</given-names>
</name>
<name>
<surname>Pardon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Söderholm</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Tack</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia</article-title>
<source/>Gut
          <year>2014</year>
<volume>63</volume>
<fpage>262</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2012-303857</pub-id>
<pub-id pub-id-type="pmid">23474421</pub-id>
</element-citation>
</ref>
<ref id="B24-jcm-07-00521">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giamarellos-Bourboulis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pyleris</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pistiki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barbatzas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Harkins</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Weitsman</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome</article-title>
<source/>Scand. J. Gastroenterol.
          <year>2015</year>
<volume>50</volume>
<fpage>1076</fpage>
<lpage>1087</lpage>
<pub-id pub-id-type="doi">10.3109/00365521.2015.1027261</pub-id>
<pub-id pub-id-type="pmid">25865706</pub-id>
</element-citation>
</ref>
<ref id="B25-jcm-07-00521">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martínez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pigrau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>González-Castro</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guilarte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guilá</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Torres</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Azpiroz</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diarrhoea-predominant irritable bowel syndrome: An organic disorder with structural abnormalities in the jejunal epithelial barrier</article-title>
<source/>Gut
          <year>2013</year>
<volume>62</volume>
<fpage>1160</fpage>
<lpage>1168</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2012-302093</pub-id>
<pub-id pub-id-type="pmid">22637702</pub-id>
</element-citation>
</ref>
<ref id="B26-jcm-07-00521">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Stanghellini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>de Giorgio</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cremon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di Nardo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trevisani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Campi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Geppetti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tonini</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome</article-title>
<source/>Gastroenterology
          <year>2007</year>
<volume>132</volume>
<fpage>26</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2006.11.039</pub-id>
<pub-id pub-id-type="pmid">17241857</pub-id>
</element-citation>
</ref>
<ref id="B27-jcm-07-00521">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rezaie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Riddle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Psychological disorders in gastrointestinal disease: Epiphenomenon, cause or consequence?</article-title>
<source/>Ann. Gastroenterol.
          <year>2014</year>
<volume>27</volume>
<fpage>224</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="pmid">24974805</pub-id>
</element-citation>
</ref>
<ref id="B28-jcm-07-00521">
<label>28.</label>
<element-citation publication-type="web">
<article-title>Gastrointestinal Symptoms in Psychiatry: Comparison of Direct Applications and Referrals</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.dusunenadamdergisi.org/ing/fArticledetails.aspx?MkID=1125">http://www.dusunenadamdergisi.org/ing/fArticledetails.aspx?MkID=1125</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-11-19">(accessed on 19 November 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B29-jcm-07-00521">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilder-Smith</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Olesen</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Materna</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Drewes</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Fermentable sugar ingestion, gas production, and gastrointestinal and central nervous system symptoms in patients with functional disorders</article-title>
<source/>Gastroenterology
          <year>2018</year>
<volume>155</volume>
<fpage>1034</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2018.07.013</pub-id>
<pub-id pub-id-type="pmid">30009815</pub-id>
</element-citation>
</ref>
<ref id="B30-jcm-07-00521">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Codagnone</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Spichak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>O’Mahony</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>O’Leary</surname>
<given-names>O.F.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Programming bugs: Microbiota and the developmental origins of brain health and disease</article-title>
<source/>Biol. Psychiatry
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2018.06.014</pub-id>
</element-citation>
</ref>
<ref id="B31-jcm-07-00521">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luczynski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>S.O.</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Adult microbiota-deficient mice have distinct dendritic morphological changes: Differential effects in the amygdala and hippocampus</article-title>
<source/>Eur. J. Neurosci.
          <year>2016</year>
<volume>44</volume>
<fpage>2654</fpage>
<lpage>2666</lpage>
<pub-id pub-id-type="doi">10.1111/ejn.13291</pub-id>
<pub-id pub-id-type="pmid">27256072</pub-id>
</element-citation>
</ref>
<ref id="B32-jcm-07-00521">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoban</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Claesson</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Regulation of prefrontal cortex myelination by the microbiota</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>774</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.42</pub-id>
</element-citation>
</ref>
<ref id="B33-jcm-07-00521">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cluette-Brown</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Claud</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Effects of intestinal microbiota on brain development in humanized gnotobiotic mice</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>5443</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-23692-w</pub-id>
<pub-id pub-id-type="pmid">29615691</pub-id>
</element-citation>
</ref>
<ref id="B34-jcm-07-00521">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desbonnet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Microbiota is essential for social development in the mouse</article-title>
<source/>Mol. Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>146</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.65</pub-id>
<pub-id pub-id-type="pmid">23689536</pub-id>
</element-citation>
</ref>
<ref id="B35-jcm-07-00521">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Poniewierska-Baran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rzeszotek</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bartoszewski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Skonieczna-Żydecka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Starzyńska</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
</person-group>
<article-title>A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<elocation-id>e0189337</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0189337</pub-id>
<pub-id pub-id-type="pmid">29494614</pub-id>
</element-citation>
</ref>
<ref id="B36-jcm-07-00521">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaelberer</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Montoya</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bohórquez</surname>
<given-names>D.V.</given-names>
</name>
</person-group>
<article-title>A gut-brain neural circuit for nutrient sensory transduction</article-title>
<source/>Science
          <year>2018</year>
<volume>361</volume>
<pub-id pub-id-type="doi">10.1126/science.aat5236</pub-id>
</element-citation>
</ref>
<ref id="B37-jcm-07-00521">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paolicelli</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Bergamini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rajendran</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Cell-to-cell communication by extracellular vesicles: Focus on microglia</article-title>
<source/>Neuroscience
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.04.003</pub-id>
</element-citation>
</ref>
<ref id="B38-jcm-07-00521">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kavvadia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Santis</surname>
<given-names>G.L.D.</given-names>
</name>
<name>
<surname>Cascapera</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lorenzo</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Psychobiotics as integrative therapy for neuropsychiatric disorders with special emphasis on the microbiota-gut-brain axis</article-title>
<source/>Biomed. Prev.
          <year>2017</year>
<volume>2</volume>
<fpage>8</fpage>
<pub-id pub-id-type="doi">10.19252/00000006F</pub-id>
</element-citation>
</ref>
<ref id="B39-jcm-07-00521">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riboni</surname>
<given-names>F.V.</given-names>
</name>
<name>
<surname>Belzung</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Stress and psychiatric disorders: From categorical to dimensional approaches</article-title>
<source/>Curr. Opin. Behav. Sci.
          <year>2017</year>
<volume>14</volume>
<fpage>72</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.cobeha.2016.12.011</pub-id>
</element-citation>
</ref>
<ref id="B40-jcm-07-00521">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.-N.</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koga</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>
<source/>J. Physiol. (Lond.)
          <year>2004</year>
<volume>558</volume>
<fpage>263</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>
<pub-id pub-id-type="pmid">15133062</pub-id>
</element-citation>
</ref>
<ref id="B41-jcm-07-00521">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crumeyrolle-Arias</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jaglin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vancassel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cardona</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Daugé</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Naudon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rabot</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats</article-title>
<source/>Psychoneuroendocrinology
          <year>2014</year>
<volume>42</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.01.014</pub-id>
<pub-id pub-id-type="pmid">24636517</pub-id>
</element-citation>
</ref>
<ref id="B42-jcm-07-00521">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>König</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>García-Ródenas</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mercenier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Whyte</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brummer</surname>
<given-names>R.-J.</given-names>
</name>
</person-group>
<article-title>Human intestinal barrier function in health and disease</article-title>
<source/>Clin. Transl. Gastroenterol.
          <year>2016</year>
<volume>7</volume>
<fpage>196</fpage>
<pub-id pub-id-type="doi">10.1038/ctg.2016.54</pub-id>
</element-citation>
</ref>
<ref id="B43-jcm-07-00521">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fond</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Boukouaci</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chevalier</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Regnault</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eberl</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hamdani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dickerson</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Macgregor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boyer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dargel</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review</article-title>
<source/>Pathol. Biol.
          <year>2015</year>
<volume>63</volume>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.patbio.2014.10.003</pub-id>
<pub-id pub-id-type="pmid">25468489</pub-id>
</element-citation>
</ref>
<ref id="B44-jcm-07-00521">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spadoni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zagato</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bertocchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paolinelli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hot</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Di Sabatino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caprioli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bottiglieri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Oldani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Viale</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A gut-vascular barrier controls the systemic dissemination of bacteria</article-title>
<source/>Science
          <year>2015</year>
<volume>350</volume>
<fpage>830</fpage>
<lpage>834</lpage>
<pub-id pub-id-type="doi">10.1126/science.aad0135</pub-id>
<pub-id pub-id-type="pmid">26564856</pub-id>
</element-citation>
</ref>
<ref id="B45-jcm-07-00521">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Sadarangani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>B.B.</given-names>
</name>
</person-group>
<article-title>The role of the immune system in governing host-microbe interactions in the intestine</article-title>
<source/>Nat. Immunol.
          <year>2013</year>
<volume>14</volume>
<fpage>660</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="doi">10.1038/ni.2611</pub-id>
<pub-id pub-id-type="pmid">23778793</pub-id>
</element-citation>
</ref>
<ref id="B46-jcm-07-00521">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groschwitz</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Intestinal barrier function: Molecular regulation and disease pathogenesis</article-title>
<source/>J. Allergy Clin. Immunol.
          <year>2009</year>
<volume>124</volume>
<fpage>3</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2009.05.038</pub-id>
<pub-id pub-id-type="pmid">19560575</pub-id>
</element-citation>
</ref>
<ref id="B47-jcm-07-00521">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lammers</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Goldblum</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shea-Donohue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Netzel-Arnett</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Buzza</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Antalis</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>16799</fpage>
<lpage>16804</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0906773106</pub-id>
<pub-id pub-id-type="pmid">19805376</pub-id>
</element-citation>
</ref>
<ref id="B48-jcm-07-00521">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasano</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer</article-title>
<source/>Physiol. Rev.
          <year>2011</year>
<volume>91</volume>
<fpage>151</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00003.2008</pub-id>
<pub-id pub-id-type="pmid">21248165</pub-id>
</element-citation>
</ref>
<ref id="B49-jcm-07-00521">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>The central nervous system and the gut microbiome</article-title>
<source/>Cell.
          <year>2016</year>
<volume>167</volume>
<fpage>915</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id>
<pub-id pub-id-type="pmid">27814521</pub-id>
</element-citation>
</ref>
<ref id="B50-jcm-07-00521">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Asmakh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zadjali</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rafter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Gut microbial communities modulating brain development and function</article-title>
<source/>Gut Microbes
          <year>2012</year>
<volume>3</volume>
<fpage>366</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.4161/gmic.21287</pub-id>
<pub-id pub-id-type="pmid">22743758</pub-id>
</element-citation>
</ref>
<ref id="B51-jcm-07-00521">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daneman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rescigno</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The gut immune barrier and the blood-brain barrier: Are they so different?</article-title>
<source/>Immunity
          <year>2009</year>
<volume>31</volume>
<fpage>722</fpage>
<lpage>735</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2009.09.012</pub-id>
<pub-id pub-id-type="pmid">19836264</pub-id>
</element-citation>
</ref>
<ref id="B52-jcm-07-00521">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Craske</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Naliboff</surname>
<given-names>B.D.</given-names>
</name>
</person-group>
<article-title>Depression, anxiety, and the gastrointestinal system</article-title>
<source/>J. Clin. Psychiatry
          <year>2001</year>
<volume>62</volume>
<issue>Suppl. 8</issue>
<fpage>28</fpage>
<lpage>37</lpage>
</element-citation>
</ref>
<ref id="B53-jcm-07-00521">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carding</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verbeke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vipond</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Corfe</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Dysbiosis of the gut microbiota in disease</article-title>
<source/>Microb. Ecol. Health Dis.
          <year>2015</year>
<volume>26</volume>
<fpage>26191</fpage>
<pub-id pub-id-type="doi">10.3402/mehd.v26.26191</pub-id>
<pub-id pub-id-type="pmid">25651997</pub-id>
</element-citation>
</ref>
<ref id="B54-jcm-07-00521">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothschild</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weissbrod</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Barkan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kurilshikov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Korem</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zeevi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Costea</surname>
<given-names>P.I.</given-names>
</name>
<name>
<surname>Godneva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalka</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>Bar</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<fpage>210</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1038/nature25973</pub-id>
<pub-id pub-id-type="pmid">29489753</pub-id>
</element-citation>
</ref>
<ref id="B55-jcm-07-00521">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Neufeld</surname>
<given-names>K.-A.M.</given-names>
</name>
</person-group>
<article-title>Gut-brain axis: How the microbiome influences anxiety and depression</article-title>
<source/>Trends Neurosci.
          <year>2013</year>
<volume>36</volume>
<fpage>305</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.01.005</pub-id>
<pub-id pub-id-type="pmid">23384445</pub-id>
</element-citation>
</ref>
<ref id="B56-jcm-07-00521">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherwin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Recent developments in understanding the role of the gut microbiota in brain health and disease</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2018</year>
<volume>1420</volume>
<fpage>5</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.13416</pub-id>
<pub-id pub-id-type="pmid">28768369</pub-id>
</element-citation>
</ref>
<ref id="B57-jcm-07-00521">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M.-L.</given-names>
</name>
<name>
<surname>Licinio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wesselingh</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways</article-title>
<source/>Mol. Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>738</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.50</pub-id>
<pub-id pub-id-type="pmid">27090305</pub-id>
</element-citation>
</ref>
<ref id="B58-jcm-07-00521">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastiaanssen</surname>
<given-names>T.F.S.</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>C.S.M.</given-names>
</name>
<name>
<surname>Claesson</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Making sense of … the microbiome in psychiatry</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1093/ijnp/pyy067</pub-id>
</element-citation>
</ref>
<ref id="B59-jcm-07-00521">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grochowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wojnar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Radkowski</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The gut microbiota in neuropsychiatric disorders</article-title>
<source/>Acta Neurobiol. Exp.
          <year>2018</year>
<volume>78</volume>
<fpage>69</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.21307/ane-2018-008</pub-id>
</element-citation>
</ref>
<ref id="B60-jcm-07-00521">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aizawa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Asahara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Teraishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koga</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder</article-title>
<source/>J. Affect. Disord.
          <year>2016</year>
<volume>202</volume>
<fpage>254</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2016.05.038</pub-id>
<pub-id pub-id-type="pmid">27288567</pub-id>
</element-citation>
</ref>
<ref id="B61-jcm-07-00521">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered fecal microbiota composition in patients with major depressive disorder</article-title>
<source/>Brain Behav. Immun.
          <year>2015</year>
<volume>48</volume>
<fpage>186</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2015.03.016</pub-id>
<pub-id pub-id-type="pmid">25882912</pub-id>
</element-citation>
</ref>
<ref id="B62-jcm-07-00521">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szczesniak</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hestad</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Rudi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Isovaleric acid in stool correlates with human depression</article-title>
<source/>Nutr. Neurosci.
          <year>2016</year>
<volume>19</volume>
<fpage>279</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1179/1476830515Y.0000000007</pub-id>
<pub-id pub-id-type="pmid">25710209</pub-id>
</element-citation>
</ref>
<ref id="B63-jcm-07-00521">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogyu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tsugawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Omura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tarumi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Plitman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Moriguchi</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kynurenine pathway in depression: A systematic review and meta-analysis</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2018</year>
<volume>90</volume>
<fpage>16</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.03.023</pub-id>
<pub-id pub-id-type="pmid">29608993</pub-id>
</element-citation>
</ref>
<ref id="B64-jcm-07-00521">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Maukonen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hyytiäinen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kieseppä</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Orešič</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sabunciyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mantere</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Saarela</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suvisaari</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response</article-title>
<source/>Schizophr. Res.
          <year>2018</year>
<volume>192</volume>
<fpage>398</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2017.04.017</pub-id>
<pub-id pub-id-type="pmid">28442250</pub-id>
</element-citation>
</ref>
<ref id="B65-jcm-07-00521">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study</article-title>
<source/>Schizophr. Res.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.schres.2018.01.002</pub-id>
</element-citation>
</ref>
<ref id="B66-jcm-07-00521">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Bassis</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Hein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Assari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Flowers</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>V.B.</given-names>
</name>
<name>
<surname>Ellingrod</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>McInnis</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>The gut microbiome composition associates with bipolar disorder and illness severity</article-title>
<source/>J. Psychiatr. Res.
          <year>2017</year>
<volume>87</volume>
<fpage>23</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.12.007</pub-id>
<pub-id pub-id-type="pmid">27988330</pub-id>
</element-citation>
</ref>
<ref id="B67-jcm-07-00521">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Painold</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mörkl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kashofer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Halwachs</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dalkner</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bengesser</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Birner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fellendorf</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Platzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Queissner</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode</article-title>
<source/>Bipolar Disord.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1111/bdi.12682</pub-id>
</element-citation>
</ref>
<ref id="B68-jcm-07-00521">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keshavarzian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Engen</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Naqib</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forsyth</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Mutlu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Colonic bacterial composition in Parkinson’s disease</article-title>
<source/>Mov. Disord.
          <year>2015</year>
<volume>30</volume>
<fpage>1351</fpage>
<lpage>1360</lpage>
<pub-id pub-id-type="doi">10.1002/mds.26307</pub-id>
<pub-id pub-id-type="pmid">26179554</pub-id>
</element-citation>
</ref>
<ref id="B69-jcm-07-00521">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Angelis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Francavilla</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De Giacomo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gobbetti</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders and intestinal microbiota</article-title>
<source/>Gut Microbes
          <year>2015</year>
<volume>6</volume>
<fpage>207</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1080/19490976.2015.1035855</pub-id>
<pub-id pub-id-type="pmid">25835343</pub-id>
</element-citation>
</ref>
<ref id="B70-jcm-07-00521">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kushak</surname>
<given-names>R.I.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Buie</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>N.L.</given-names>
</name>
</person-group>
<article-title>Analysis of the Duodenal Microbiome in Autistic Individuals: Association With Carbohydrate Digestion</article-title>
<source/>J. Pediatr. Gastroenterol. Nutr.
          <year>2017</year>
<volume>64</volume>
<fpage>110</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1097/MPG.0000000000001458</pub-id>
</element-citation>
</ref>
<ref id="B71-jcm-07-00521">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.-H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>B.-R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.-K.</given-names>
</name>
<name>
<surname>Seoh</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>P.-L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.-J.</given-names>
</name>
</person-group>
<article-title>Rapid assessment of microbiota changes in individuals with autism spectrum disorder using bacteria-derived membrane vesicles in urine</article-title>
<source/>Exp. Neurobiol.
          <year>2017</year>
<volume>26</volume>
<fpage>307</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.5607/en.2017.26.5.307</pub-id>
<pub-id pub-id-type="pmid">29093639</pub-id>
</element-citation>
</ref>
<ref id="B72-jcm-07-00521">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Donati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jousson</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Leoncini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Renzi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Calabrò</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>New evidences on the altered gut microbiota in autism spectrum disorders</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0242-1</pub-id>
<pub-id pub-id-type="pmid">28222761</pub-id>
</element-citation>
</ref>
<ref id="B73-jcm-07-00521">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryn</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Skjeldal</surname>
<given-names>O.H.</given-names>
</name>
<name>
<surname>Saugstad</surname>
<given-names>O.D.</given-names>
</name>
<name>
<surname>Ormstad</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Kynurenine pathway in autism spectrum disorders in children</article-title>
<source/>Neuropsychobiology
          <year>2017</year>
<volume>76</volume>
<fpage>82</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1159/000488157</pub-id>
<pub-id pub-id-type="pmid">29694960</pub-id>
</element-citation>
</ref>
<ref id="B74-jcm-07-00521">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aarts</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ederveen</surname>
<given-names>T.H.A.</given-names>
</name>
<name>
<surname>Naaijen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zwiers</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Boekhorst</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Timmerman</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Smeekens</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Netea</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome in ADHD and its relation to neural reward anticipation</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<elocation-id>e0183509</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0183509</pub-id>
<pub-id pub-id-type="pmid">28863139</pub-id>
</element-citation>
</ref>
<ref id="B75-jcm-07-00521">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cattaneo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cattane</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Galluzzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Provasi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lopizzo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Festari</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guerra</surname>
<given-names>U.P.</given-names>
</name>
<name>
<surname>Paghera</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Muscio</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly</article-title>
<source/>Neurobiol. Aging
          <year>2017</year>
<volume>49</volume>
<fpage>60</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.08.019</pub-id>
<pub-id pub-id-type="pmid">27776263</pub-id>
</element-citation>
</ref>
<ref id="B76-jcm-07-00521">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogt</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Kerby</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Dill-McFarland</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Merluzzi</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Asthana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zetterberg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Blennow</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome alterations in Alzheimer’s disease</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>13537</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-13601-y</pub-id>
<pub-id pub-id-type="pmid">29051531</pub-id>
</element-citation>
</ref>
<ref id="B77-jcm-07-00521">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cekanaviciute</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Runia</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>Debelius</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Kanner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bencosme</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>S.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>10713</fpage>
<lpage>10718</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1711235114</pub-id>
<pub-id pub-id-type="pmid">28893978</pub-id>
</element-citation>
</ref>
<ref id="B78-jcm-07-00521">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwensen</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Treasure</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Høiby</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sjögren</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A systematic review of studies on the faecal microbiota in anorexia nervosa: Future research may need to include microbiota from the small intestine</article-title>
<source/>Eat. Weight Disord.
          <year>2018</year>
<volume>23</volume>
<fpage>399</fpage>
<lpage>418</lpage>
<pub-id pub-id-type="doi">10.1007/s40519-018-0499-9</pub-id>
<pub-id pub-id-type="pmid">29542066</pub-id>
</element-citation>
</ref>
<ref id="B79-jcm-07-00521">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Dowd</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Galley</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Hufnagle</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Lyte</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation</article-title>
<source/>Brain Behav. Immun.
          <year>2011</year>
<volume>25</volume>
<fpage>397</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2010.10.023</pub-id>
<pub-id pub-id-type="pmid">21040780</pub-id>
</element-citation>
</ref>
<ref id="B80-jcm-07-00521">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zijlmans</surname>
<given-names>M.A.C.</given-names>
</name>
<name>
<surname>Korpela</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Riksen-Walraven</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>de Weerth</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Maternal prenatal stress is associated with the infant intestinal microbiota</article-title>
<source/>Psychoneuroendocrinology
          <year>2015</year>
<volume>53</volume>
<fpage>233</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.01.006</pub-id>
<pub-id pub-id-type="pmid">25638481</pub-id>
</element-citation>
</ref>
<ref id="B81-jcm-07-00521">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarandi</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Treisman</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Pasricha</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>modulatory effects of gut microbiota on the central nervous system: how gut could play a role in neuropsychiatric health and diseases</article-title>
<source/>J. Neurogastroenterol. Motil.
          <year>2016</year>
<volume>22</volume>
<fpage>201</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.5056/jnm15146</pub-id>
<pub-id pub-id-type="pmid">27032544</pub-id>
</element-citation>
</ref>
<ref id="B82-jcm-07-00521">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hyland</surname>
<given-names>N.P.</given-names>
</name>
</person-group>
<article-title>Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders</article-title>
<source/>Front. Cell. Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>392</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00392</pub-id>
<pub-id pub-id-type="pmid">26528128</pub-id>
</element-citation>
</ref>
<ref id="B83-jcm-07-00521">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ait-Belgnaoui</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bradesi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fioramonti</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Theodorou</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bueno</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: Role of myosin light chain kinase</article-title>
<source/>Pain
          <year>2005</year>
<volume>113</volume>
<fpage>141</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/j.pain.2004.10.002</pub-id>
<pub-id pub-id-type="pmid">15621374</pub-id>
</element-citation>
</ref>
<ref id="B84-jcm-07-00521">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winter</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Charlesworth</surname>
<given-names>R.P.G.</given-names>
</name>
<name>
<surname>Sharpley</surname>
<given-names>C.F.</given-names>
</name>
</person-group>
<article-title>Gut microbiome and depression: What we know and what we need to know</article-title>
<source/>Rev. Neurosci.
          <year>2018</year>
<volume>29</volume>
<fpage>629</fpage>
<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1515/revneuro-2017-0072</pub-id>
<pub-id pub-id-type="pmid">29397391</pub-id>
</element-citation>
</ref>
<ref id="B85-jcm-07-00521">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Inflammation in psychiatric disorders: What comes first?</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1111/nyas.13712</pub-id>
</element-citation>
</ref>
<ref id="B86-jcm-07-00521">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spiller</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome</article-title>
<source/>J. Neurogastroenterol. Motil.
          <year>2012</year>
<volume>18</volume>
<fpage>258</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.5056/jnm.2012.18.3.258</pub-id>
<pub-id pub-id-type="pmid">22837873</pub-id>
</element-citation>
</ref>
<ref id="B87-jcm-07-00521">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Futagami</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Systematic review with meta-analysis: Post-infectious functional dyspepsia</article-title>
<source/>Aliment. Pharmacol. Ther.
          <year>2015</year>
<volume>41</volume>
<fpage>177</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1111/apt.13006</pub-id>
<pub-id pub-id-type="pmid">25348873</pub-id>
</element-citation>
</ref>
<ref id="B88-jcm-07-00521">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuendorf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stello</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hanes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wahbeh</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review</article-title>
<source/>J. Psychosom. Res.
          <year>2016</year>
<volume>87</volume>
<fpage>70</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychores.2016.06.001</pub-id>
<pub-id pub-id-type="pmid">27411754</pub-id>
</element-citation>
</ref>
<ref id="B89-jcm-07-00521">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Pedziwiatr</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cymer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kucharska-Mazur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Samochowiec</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Sterile inflammation of brain, due to activation of innate immunity, as a culprit in psychiatric disorders</article-title>
<source/>Front. Psychiatry
          <year>2018</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00060</pub-id>
</element-citation>
</ref>
<ref id="B90-jcm-07-00521">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Wnt signaling in stem cells and cancer stem cells: A tale of two coactivators</article-title>
<source/>Prog. Mol. Biol. Transl. Sci.
          <year>2018</year>
<volume>153</volume>
<fpage>209</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/bs.pmbts.2017.11.007</pub-id>
<pub-id pub-id-type="pmid">29389517</pub-id>
</element-citation>
</ref>
<ref id="B91-jcm-07-00521">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabiri</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zaribafzadeh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hemmerich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Counter</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Virshup</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells</article-title>
<source/>J. Clin. Invest.
          <year>2018</year>
<volume>128</volume>
<fpage>3806</fpage>
<lpage>3812</lpage>
<pub-id pub-id-type="doi">10.1172/JCI99325</pub-id>
<pub-id pub-id-type="pmid">30059017</pub-id>
</element-citation>
</ref>
<ref id="B92-jcm-07-00521">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Anbarchian</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Plant</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling regulates ependymal cell development and adult homeostasis</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>5954</fpage>
<lpage>5962</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1803297115</pub-id>
</element-citation>
</ref>
<ref id="B93-jcm-07-00521">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Blogowski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Starzynska</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wojakowski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zuba-Surma</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Identification of very small embryonic/epiblast-like stem cells (VSELs) circulating in peripheral blood during organ/tissue injuries</article-title>
<source/>Methods Cell. Biol.
          <year>2011</year>
<volume>103</volume>
<fpage>31</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/B978-0-12-385493-3.00003-6</pub-id>
<pub-id pub-id-type="pmid">21722799</pub-id>
</element-citation>
</ref>
<ref id="B94-jcm-07-00521">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wojakowski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tendera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zuba-Surma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Paczkowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ciosek</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hałasa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Król</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kazmierski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buszman</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction</article-title>
<source/>J. Am. Coll. Cardiol.
          <year>2009</year>
<volume>53</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2008.09.029</pub-id>
<pub-id pub-id-type="pmid">19118716</pub-id>
</element-citation>
</ref>
<ref id="B95-jcm-07-00521">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paczkowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koziarska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Halasa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Safranow</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Masiuk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karbicka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nowik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nowacki</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke</article-title>
<source/>Stroke
          <year>2009</year>
<volume>40</volume>
<fpage>1237</fpage>
<lpage>1244</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.108.535062</pub-id>
<pub-id pub-id-type="pmid">19246697</pub-id>
</element-citation>
</ref>
<ref id="B96-jcm-07-00521">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drukała</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paczkowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Młyńska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Krajewski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Machaliński</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Madeja</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
</person-group>
<article-title>Stem cells, including a population of very small embryonic-like stem cells, are mobilized into peripheral blood in patients after skin burn injury</article-title>
<source/>Stem Cell. Rev.
          <year>2012</year>
<volume>8</volume>
<fpage>184</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-011-9272-4</pub-id>
<pub-id pub-id-type="pmid">21573962</pub-id>
</element-citation>
</ref>
<ref id="B97-jcm-07-00521">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zuba-Surma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blogowski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Starzynska</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
</person-group>
<article-title>Various types of stem cells, including a population of very small embryonic-like stem cells, are mobilized into peripheral blood in patients with Crohn’s disease</article-title>
<source/>Inflamm. Bowel Dis.
          <year>2012</year>
<volume>18</volume>
<fpage>1711</fpage>
<lpage>1722</lpage>
<pub-id pub-id-type="doi">10.1002/ibd.22875</pub-id>
<pub-id pub-id-type="pmid">22238186</pub-id>
</element-citation>
</ref>
<ref id="B98-jcm-07-00521">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stonesifer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Corey</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghanekar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Diamandis</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Acosta</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Borlongan</surname>
<given-names>C.V.</given-names>
</name>
</person-group>
<article-title>Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms</article-title>
<source/>Prog. Neurobiol.
          <year>2017</year>
<volume>158</volume>
<fpage>94</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2017.07.004</pub-id>
<pub-id pub-id-type="pmid">28743464</pub-id>
</element-citation>
</ref>
<ref id="B99-jcm-07-00521">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratajczak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zuba-Surma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Paczkowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nowacki</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
</person-group>
<article-title>Stem cells for neural regeneration—A potential application of very small embryonic-like stem cells</article-title>
<source/>J. Physiol. Pharmacol.
          <year>2011</year>
<volume>62</volume>
<fpage>3</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">21451204</pub-id>
</element-citation>
</ref>
<ref id="B100-jcm-07-00521">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Abdel-Latif</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mierzejewska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sunkara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Borkowska</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
</person-group>
<article-title>Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells--implications for tissue regeneration</article-title>
<source/>Stem Cells
          <year>2013</year>
<volume>31</volume>
<fpage>500</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1291</pub-id>
<pub-id pub-id-type="pmid">23193025</pub-id>
</element-citation>
</ref>
<ref id="B101-jcm-07-00521">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jabłoński</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Tarnowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dołęgowska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pędziwiatr</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kubiś</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Budkowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sałata</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wysiecka</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Kazimierczak</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mobilization of peripheral blood stem cells and changes in the concentration of plasma factors influencing their movement in patients with panic disorder</article-title>
<source/>Stem Cell. Rev.
          <year>2017</year>
<volume>13</volume>
<fpage>217</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-016-9700-6</pub-id>
<pub-id pub-id-type="pmid">27914035</pub-id>
</element-citation>
</ref>
<ref id="B102-jcm-07-00521">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adamiak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bujko</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cymer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Plonka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Glaser</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kucia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Abdel-Latif</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
</person-group>
<article-title>Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells</article-title>
<source/>Leukemia
          <year>2018</year>
<volume>32</volume>
<fpage>1920</fpage>
<lpage>1931</lpage>
<pub-id pub-id-type="doi">10.1038/s41375-018-0122-0</pub-id>
<pub-id pub-id-type="pmid">29725032</pub-id>
</element-citation>
</ref>
<ref id="B103-jcm-07-00521">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Janowska-Wieczorek</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Innate immunity as orchestrator of bone marrow homing for hematopoietic stem/progenitor cells</article-title>
<source/>Adv. Exp. Med. Biol.
          <year>2013</year>
<volume>735</volume>
<fpage>219</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="pmid">23402030</pub-id>
</element-citation>
</ref>
<ref id="B104-jcm-07-00521">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>extracellular microvesicles as game changers in better understanding the complexity of cellular interactions-from bench to clinical applications</article-title>
<source/>Am. J. Med. Sci.
          <year>2017</year>
<volume>354</volume>
<fpage>449</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjms.2017.06.001</pub-id>
<pub-id pub-id-type="pmid">29173353</pub-id>
</element-citation>
</ref>
<ref id="B105-jcm-07-00521">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kucharska-Mazur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tarnowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dołęgowska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Budkowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pędziwiatr</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jabłoński</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pełka-Wysiecka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kazimierczak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ratajczak</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Samochowiec</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Novel evidence for enhanced stem cell trafficking in antipsychotic-naïve subjects during their first psychotic episode</article-title>
<source/>J. Psychiatr. Res.
          <year>2014</year>
<volume>49</volume>
<fpage>18</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.10.016</pub-id>
<pub-id pub-id-type="pmid">24246416</pub-id>
</element-citation>
</ref>
<ref id="B106-jcm-07-00521">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Reder</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>The direct effects of fingolimod in the central nervous system: Implications for relapsing multiple sclerosis</article-title>
<source/>CNS Drugs
          <year>2016</year>
<volume>30</volume>
<fpage>135</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1007/s40263-015-0297-0</pub-id>
<pub-id pub-id-type="pmid">26715391</pub-id>
</element-citation>
</ref>
<ref id="B107-jcm-07-00521">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mutneja</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vij</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Ozanimod treatment for ulcerative colitis</article-title>
<source/>N. Engl. J. Med.
          <year>2016</year>
<volume>375</volume>
<fpage>e17</fpage>
<pub-id pub-id-type="doi">10.1056/NEJMc1607287</pub-id>
</element-citation>
</ref>
<ref id="B108-jcm-07-00521">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szulińska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Łoniewski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>van Hemert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sobieska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bogdański</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Dose-dependent effects of multispecies probiotic supplementation on the lipopolysaccharide (LPS) level and cardiometabolic profile in obese postmenopausal women: A 12-week randomized clinical trial</article-title>
<source/>Nutrients
          <year>2018</year>
<volume>10</volume>
<elocation-id>773</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu10060773</pub-id>
</element-citation>
</ref>
<ref id="B109-jcm-07-00521">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Loniewski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Grimes</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: Contrasting interactions in the stomach and small intestine</article-title>
<source/>Mayo Clin. Proc.
          <year>2014</year>
<volume>89</volume>
<fpage>1699</fpage>
<lpage>1709</lpage>
<pub-id pub-id-type="doi">10.1016/j.mayocp.2014.07.015</pub-id>
<pub-id pub-id-type="pmid">25440891</pub-id>
</element-citation>
</ref>
<ref id="B110-jcm-07-00521">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Bastard</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Al-Ghalith</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Grégoire</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chapelet</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Javaudin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dailly</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Batard</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Knights</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Montassier</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Systematic review: Human gut dysbiosis induced by non-antibiotic prescription medications</article-title>
<source/>Aliment. Pharmacol. Ther.
          <year>2018</year>
<volume>47</volume>
<fpage>332</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1111/apt.14451</pub-id>
<pub-id pub-id-type="pmid">29205415</pub-id>
</element-citation>
</ref>
<ref id="B111-jcm-07-00521">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utzeri</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Usai</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease</article-title>
<source/>World J. Gastroenterol.
          <year>2017</year>
<volume>23</volume>
<fpage>3954</fpage>
<lpage>3963</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v23.i22.3954</pub-id>
<pub-id pub-id-type="pmid">28652650</pub-id>
</element-citation>
</ref>
<ref id="B112-jcm-07-00521">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Syer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Denou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>de Palma</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>McKnight</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jury</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bolla</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bercik</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>S.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis</article-title>
<source/>Gastroenterology
          <year>2011</year>
<volume>141</volume>
<pub-id pub-id-type="doi">10.1053/j.gastro.2011.06.075</pub-id>
</element-citation>
</ref>
<ref id="B113-jcm-07-00521">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pruteanu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Telzerow</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Brochado</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Dose</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Extensive impact of non-antibiotic drugs on human gut bacteria</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<fpage>623</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="doi">10.1038/nature25979</pub-id>
<pub-id pub-id-type="pmid">29555994</pub-id>
</element-citation>
</ref>
<ref id="B114-jcm-07-00521">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koliada</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Syzenko</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Moseiko</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Budovska</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Puchkov</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Perederiy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gavalko</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dorofeyev</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Romanenko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tkach</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population</article-title>
<source/>BMC Microbiol.
          <year>2017</year>
<volume>17</volume>
<pub-id pub-id-type="doi">10.1186/s12866-017-1027-1</pub-id>
</element-citation>
</ref>
<ref id="B115-jcm-07-00521">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davey</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>O’Mahony</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Schellekens</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Gender-dependent consequences of chronic olanzapine in the rat: Effects on body weight, inflammatory, metabolic and microbiota parameters</article-title>
<source/>Psychopharmacology (Berl.)
          <year>2012</year>
<volume>221</volume>
<fpage>155</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-011-2555-2</pub-id>
<pub-id pub-id-type="pmid">22234378</pub-id>
</element-citation>
</ref>
<ref id="B116-jcm-07-00521">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davey</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Crispie</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>O’Mahony</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Antipsychotics and the gut microbiome: Olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat</article-title>
<source/>Transl. Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>309</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.83</pub-id>
</element-citation>
</ref>
<ref id="B117-jcm-07-00521">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahr</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Weidemann</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>deLeon</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Burnett</surname>
<given-names>C.M.L.</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Murry</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Grobe</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure</article-title>
<source/>EBioMedicine
          <year>2015</year>
<volume>2</volume>
<fpage>1725</fpage>
<lpage>1734</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2015.10.018</pub-id>
</element-citation>
</ref>
<ref id="B118-jcm-07-00521">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Crowley</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Nonneman</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Quackenbush</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Bogue</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Paredes</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Yourstone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>I.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e115225</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0115225</pub-id>
<pub-id pub-id-type="pmid">25506936</pub-id>
</element-citation>
</ref>
<ref id="B119-jcm-07-00521">
<label>119.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Castaner</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Goday</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.-M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Magkos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shiow</surname>
<given-names>S.-A.T.E.</given-names>
</name>
<name>
<surname>Schröder</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The Gut Microbiome Profile in Obesity: A Systematic Review</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.hindawi.com/journals/ije/2018/4095789/">https://www.hindawi.com/journals/ije/2018/4095789/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-10-08">(accessed on 8 October 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B120-jcm-07-00521">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahr</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Tyler</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Wooldridge</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Teesch</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Oltman</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Azcarate-Peril</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Calarge</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children</article-title>
<source/>Transl. Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>652</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.135</pub-id>
</element-citation>
</ref>
<ref id="B121-jcm-07-00521">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flowers</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>McInnis</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Ellingrod</surname>
<given-names>V.L.</given-names>
</name>
</person-group>
<article-title>Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort</article-title>
<source/>Pharmacotherapy
          <year>2017</year>
<volume>37</volume>
<fpage>261</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1002/phar.1890</pub-id>
<pub-id pub-id-type="pmid">28035686</pub-id>
</element-citation>
</ref>
<ref id="B122-jcm-07-00521">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>B.U.</given-names>
</name>
<name>
<surname>Hei</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.-F.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia</article-title>
<source/>Schizophr. Res.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.schres.2018.05.017</pub-id>
</element-citation>
</ref>
<ref id="B123-jcm-07-00521">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skonieczna-Żydecka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Łoniewski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Misera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stachowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Maciejewska</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Marlicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Galling</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Second-generation antipsychotics and metabolism alterations: A systematic review of the role of the gut microbiome</article-title>
<source/>Psychopharmacology
          <year>2018</year>
<pub-id pub-id-type="doi">10.1007/s00213-018-5102-6</pub-id>
</element-citation>
</ref>
<ref id="B124-jcm-07-00521">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Action mechanism of antitubercular isoniazid activation by <italic>Mycobacterium</italic> tuberculosis KatG, isolation, and characterization of inha inhibitor</article-title>
<source/>J. Biol. Chem.
          <year>2000</year>
<volume>275</volume>
<fpage>2520</fpage>
<lpage>2526</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.275.4.2520</pub-id>
<pub-id pub-id-type="pmid">10644708</pub-id>
</element-citation>
</ref>
<ref id="B125-jcm-07-00521">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jena</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Waghmare</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kashikar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Harinath</surname>
<given-names>B.C.</given-names>
</name>
</person-group>
<article-title>Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug</article-title>
<source/>Int. J. Mycobacteriol.
          <year>2014</year>
<volume>3</volume>
<fpage>276</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijmyco.2014.08.003</pub-id>
<pub-id pub-id-type="pmid">26786627</pub-id>
</element-citation>
</ref>
<ref id="B126-jcm-07-00521">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csiszar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Molnar</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mechanism of action of tricyclic drugs on <italic>Escherichia coli</italic> and <italic>Yersinia enterocolitica</italic> plasmid maintenance and replication</article-title>
<source/>Anticancer Res.
          <year>1992</year>
<volume>12</volume>
<fpage>2267</fpage>
<lpage>2272</lpage>
<pub-id pub-id-type="pmid">1295474</pub-id>
</element-citation>
</ref>
<ref id="B127-jcm-07-00521">
<label>127.</label>
<element-citation publication-type="web">
<article-title>Binding of Tricyclic Antidepressant Drugs to Trophozoites of Giardia Lamblia</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://jglobal.jst.go.jp/en/public/20090422/200902093831082291">http://jglobal.jst.go.jp/en/public/20090422/200902093831082291</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-09-29">(accessed on 29 September 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B128-jcm-07-00521">
<label>128.</label>
<element-citation publication-type="gov">
<article-title>Antiplasmid Activity of Tricyclic Compounds</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/3047509">https://www.ncbi.nlm.nih.gov/pubmed/3047509</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-09-29">(accessed on 29 September 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B129-jcm-07-00521">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bitonti</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Sjoerdsma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McCann</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Kyle</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Oduola</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Rossan</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Milhous</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine</article-title>
<source/>Science
          <year>1988</year>
<volume>242</volume>
<fpage>1301</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1126/science.3057629</pub-id>
<pub-id pub-id-type="pmid">3057629</pub-id>
</element-citation>
</ref>
<ref id="B130-jcm-07-00521">
<label>130.</label>
<element-citation publication-type="web">
<article-title>Antidepressants Cause Lethal Disruption of Membrane Function in the Human Protozoan Parasite Leishmania</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://science.sciencemag.org/content/226/4677/977">http://science.sciencemag.org/content/226/4677/977</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-09-29">(accessed on 29 September 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B131-jcm-07-00521">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz-Bellido</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Munoz-Criado</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Garcìa-Rodrìguez</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors</article-title>
<source/>Int. J. Antimicrob. Agents
          <year>2000</year>
<volume>14</volume>
<fpage>177</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1016/S0924-8579(99)00154-5</pub-id>
<pub-id pub-id-type="pmid">10773485</pub-id>
</element-citation>
</ref>
<ref id="B132-jcm-07-00521">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayaz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Subhan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.-U.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>N.-I.-H.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance</article-title>
<source/>J. Biol. Res. (Thessalon)
          <year>2015</year>
<volume>22</volume>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/s40709-015-0028-1</pub-id>
<pub-id pub-id-type="pmid">26029671</pub-id>
</element-citation>
</ref>
<ref id="B133-jcm-07-00521">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coban</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Tanriverdi Cayci</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Keleş Uludağ</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Durupinar</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Investigation of antibacterial activity of sertralin</article-title>
<source/>Mikrobiyol. Bul.
          <year>2009</year>
<volume>43</volume>
<fpage>651</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="pmid">20084919</pub-id>
</element-citation>
</ref>
<ref id="B134-jcm-07-00521">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kruszewska</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zareba</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tyski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Examination of antimicrobial activity of selected non-antibiotic medicinal preparations</article-title>
<source/>Acta Pol. Pharm.
          <year>2012</year>
<volume>69</volume>
<fpage>1368</fpage>
<lpage>1371</lpage>
<pub-id pub-id-type="pmid">23285704</pub-id>
</element-citation>
</ref>
<ref id="B135-jcm-07-00521">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bohnert</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Szymaniak-Vits</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schuster</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>W.V.</given-names>
</name>
</person-group>
<article-title>Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli</article-title>
<source/>J. Antimicrob. Chemother.
          <year>2011</year>
<volume>66</volume>
<fpage>2057</fpage>
<lpage>2060</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkr258</pub-id>
<pub-id pub-id-type="pmid">21700628</pub-id>
</element-citation>
</ref>
<ref id="B136-jcm-07-00521">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Begec</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yucel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yakupogullari</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Erdogan</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Duman</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Durmus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ersoy</surname>
<given-names>M.O.</given-names>
</name>
</person-group>
<article-title>The antimicrobial effects of ketamine combined with propofol: An in vitro study</article-title>
<source/>Braz J. Anesthesiol.
          <year>2013</year>
<volume>63</volume>
<fpage>461</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1016/j.bjan.2012.09.003</pub-id>
<pub-id pub-id-type="pmid">24565343</pub-id>
</element-citation>
</ref>
<ref id="B137-jcm-07-00521">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felice</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>O’Mahony</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>The microbiome and disorders of the central nervous system</article-title>
<source/>Pharmacol. Biochem. Behav.
          <year>2017</year>
<volume>160</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2017.06.016</pub-id>
<pub-id pub-id-type="pmid">28666895</pub-id>
</element-citation>
</ref>
<ref id="B138-jcm-07-00521">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mörkl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wagner-Skacel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lahousen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lackner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holasek</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Bengesser</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Painold</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Holl</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Reininghaus</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The role of nutrition and the gut-brain axis in psychiatry: A review of the literature</article-title>
<source/>Neuropsychobiology
          <year>2018</year>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1159/000492834</pub-id>
</element-citation>
</ref>
<ref id="B139-jcm-07-00521">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Gut-Brain Psychology: Rethinking psychology from the microbiota–gut–brain axis</article-title>
<source/>Front. Integr. Neurosci.
          <year>2018</year>
<volume>12</volume>
<pub-id pub-id-type="doi">10.3389/fnint.2018.00033</pub-id>
</element-citation>
</ref>
<ref id="B140-jcm-07-00521">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schmiderer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Djanani</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Gut microbiome-immune crosstalk affects progression of cancer</article-title>
<source/>Transl. Gastroenterol. Hepatol.
          <year>2018</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.21037/tgh.2018.06.02</pub-id>
</element-citation>
</ref>
<ref id="B141-jcm-07-00521">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Grander</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Microbiota and diabetes: An increasingly relevant association</article-title>
<source/>Pol. Arch. Int. Med.
          <year>2018</year>
<volume>128</volume>
<fpage>333</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.20452/pamw.4286</pub-id>
<pub-id pub-id-type="pmid">29968694</pub-id>
</element-citation>
</ref>
<ref id="B142-jcm-07-00521">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adolph</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Grander</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Moschen</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Tilg</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Liver–microbiome axis in health and disease</article-title>
<source/>Trends Immunol.
          <year>2018</year>
<volume>39</volume>
<fpage>712</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2018.05.002</pub-id>
<pub-id pub-id-type="pmid">29843959</pub-id>
</element-citation>
</ref>
<ref id="B143-jcm-07-00521">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quigley</surname>
<given-names>E.M.M.</given-names>
</name>
</person-group>
<article-title>Prebiotics and probiotics in digestive health</article-title>
<source/>Clin. Gastroenterol. Hepatol.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.cgh.2018.09.028</pub-id>
</element-citation>
</ref>
<ref id="B144-jcm-07-00521">
<label>144.</label>
<element-citation publication-type="web">
<article-title>WGO Practice Guideline —Probiotics and Prebiotics</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics">http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-10-05">(accessed on 5 October 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B145-jcm-07-00521">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Psychobiotics: A novel class of psychotropic</article-title>
<source/>Biol. Psychiatry
          <year>2013</year>
<volume>74</volume>
<fpage>720</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.05.001</pub-id>
<pub-id pub-id-type="pmid">23759244</pub-id>
</element-citation>
</ref>
<ref id="B146-jcm-07-00521">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lehto</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Harty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Burnet</surname>
<given-names>P.W.J.</given-names>
</name>
</person-group>
<article-title>Psychobiotics and the manipulation of bacteria-gut-brain signals</article-title>
<source/>Trends Neurosci.
          <year>2016</year>
<volume>39</volume>
<fpage>763</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2016.09.002</pub-id>
<pub-id pub-id-type="pmid">27793434</pub-id>
</element-citation>
</ref>
<ref id="B147-jcm-07-00521">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guarner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Merenstein</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Pot</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Canani</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Salminen</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title>
<source/>Nat. Rev. Gastroenterol. Hepatol.
          <year>2014</year>
<volume>11</volume>
<fpage>506</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2014.66</pub-id>
<pub-id pub-id-type="pmid">24912386</pub-id>
</element-citation>
</ref>
<ref id="B148-jcm-07-00521">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohanty</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Psychobiotics: A new approach for treating mental illness?</article-title>
<source/>Crit. Rev. Food Sci. Nutr.
          <year>2017</year>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1080/10408398.2017.1399860</pub-id>
</element-citation>
</ref>
<ref id="B149-jcm-07-00521">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ait-Belgnaoui</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Colom</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Braniste</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ramalho</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Marrot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cartier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Houdeau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Theodorou</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice</article-title>
<source/>Neurogastroenterol. Motil.
          <year>2014</year>
<volume>26</volume>
<fpage>510</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1111/nmo.12295</pub-id>
<pub-id pub-id-type="pmid">24372793</pub-id>
</element-citation>
</ref>
<ref id="B150-jcm-07-00521">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ait-Belgnaoui</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Payard</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rolland</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Harkat</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Braniste</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Théodorou</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title><italic>Bifidobacterium longum</italic> and <italic>Lactobacillus helveticus</italic> synergistically suppress stress-related visceral hypersensitivity through hypothalamic-pituitary-adrenal axis modulation</article-title>
<source/>J. Neurogastroenterol. Motil.
          <year>2018</year>
<volume>24</volume>
<fpage>138</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.5056/jnm16167</pub-id>
<pub-id pub-id-type="pmid">29291614</pub-id>
</element-citation>
</ref>
<ref id="B151-jcm-07-00521">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gareau</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Jury</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>MacQueen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Perdue</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation</article-title>
<source/>Gut
          <year>2007</year>
<volume>56</volume>
<fpage>1522</fpage>
<lpage>1528</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2006.117176</pub-id>
<pub-id pub-id-type="pmid">17339238</pub-id>
</element-citation>
</ref>
<ref id="B152-jcm-07-00521">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gareau</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Wine</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reardon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Probiotics prevent death caused by citrobacter rodentium infection in neonatal mice</article-title>
<source/>J. Infect. Dis.
          <year>2010</year>
<volume>201</volume>
<fpage>81</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1086/648614</pub-id>
<pub-id pub-id-type="pmid">19961304</pub-id>
</element-citation>
</ref>
<ref id="B153-jcm-07-00521">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diop</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guillou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: A double-blind, placebo-controlled, randomized trial</article-title>
<source/>Nutr. Res.
          <year>2008</year>
<volume>28</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.nutres.2007.10.001</pub-id>
<pub-id pub-id-type="pmid">19083380</pub-id>
</element-citation>
</ref>
<ref id="B154-jcm-07-00521">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messaoudi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lalonde</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Violle</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Javelot</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Desor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nejdi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bisson</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Rougeot</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pichelin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cazaubiel</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Assessment of psychotropic-like properties of a probiotic formulation (<italic>Lactobacillus helveticus</italic> R0052 and <italic>Bifidobacterium longum</italic> R0175) in rats and human subjects</article-title>
<source/>Br. J. Nutr.
          <year>2011</year>
<volume>105</volume>
<fpage>755</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114510004319</pub-id>
<pub-id pub-id-type="pmid">20974015</pub-id>
</element-citation>
</ref>
<ref id="B155-jcm-07-00521">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steenbergen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sellaro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Hemert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Colzato</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood</article-title>
<source/>Brain Behav. Immun.
          <year>2015</year>
<volume>48</volume>
<fpage>258</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2015.04.003</pub-id>
<pub-id pub-id-type="pmid">25862297</pub-id>
</element-citation>
</ref>
<ref id="B156-jcm-07-00521">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Hutch</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Borre</surname>
<given-names>Y.E.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Temko</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Bifidobacterium longum 1714 as a translational psychobiotic: Modulation of stress, electrophysiology and neurocognition in healthy volunteers</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>939</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.191</pub-id>
</element-citation>
</ref>
<ref id="B157-jcm-07-00521">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato-Kataoka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kikuchi-Hayakawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gondo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuki</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fermented milk containing <italic>Lactobacillus casei</italic> strain shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2016</year>
<volume>82</volume>
<fpage>3649</fpage>
<lpage>3658</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.04134-15</pub-id>
<pub-id pub-id-type="pmid">27208120</pub-id>
</element-citation>
</ref>
<ref id="B158-jcm-07-00521">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<fpage>100899</fpage>
<lpage>100907</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.21284</pub-id>
<pub-id pub-id-type="pmid">29246029</pub-id>
</element-citation>
</ref>
<ref id="B159-jcm-07-00521">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Effect of probiotics on depression: A systematic review and meta-analysis of randomized controlled trials</article-title>
<source/>Nutrients
          <year>2016</year>
<volume>8</volume>
<elocation-id>483</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu8080483</pub-id>
</element-citation>
</ref>
<ref id="B160-jcm-07-00521">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKean</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Naug</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nikbakht</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Amiet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Colson</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Probiotics and subclinical psychological symptoms in healthy participants: a systematic review and meta-analysis</article-title>
<source/>J. Altern Complement. Med.
          <year>2017</year>
<volume>23</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1089/acm.2016.0023</pub-id>
<pub-id pub-id-type="pmid">27841940</pub-id>
</element-citation>
</ref>
<ref id="B161-jcm-07-00521">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>Q.X.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C.Y.X.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>W.-S.</given-names>
</name>
</person-group>
<article-title>A meta-analysis of the use of probiotics to alleviate depressive symptoms</article-title>
<source/>J. Affect. Disord.
          <year>2018</year>
<volume>228</volume>
<fpage>13</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2017.11.063</pub-id>
<pub-id pub-id-type="pmid">29197739</pub-id>
</element-citation>
</ref>
<ref id="B162-jcm-07-00521">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazemi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Noorbala</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Azam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Eskandari</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Djafarian</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial</article-title>
<source/>Clin. Nutr.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.clnu.2018.04.010</pub-id>
</element-citation>
</ref>
<ref id="B163-jcm-07-00521">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reininghaus</surname>
<given-names>E.Z.</given-names>
</name>
<name>
<surname>Wetzlmair</surname>
<given-names>L.-C.</given-names>
</name>
<name>
<surname>Fellendorf</surname>
<given-names>F.T.</given-names>
</name>
<name>
<surname>Platzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Queissner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Birner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pilz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hamm</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maget</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koidl</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The impact of probiotic supplements on cognitive parameters in euthymic individuals with bipolar disorder: A pilot study</article-title>
<source/>Neuropsychobiology
          <year>2018</year>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1159/000492537</pub-id>
</element-citation>
</ref>
<ref id="B164-jcm-07-00521">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Citi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Intestinal barriers protect against disease</article-title>
<source/>Science
          <year>2018</year>
<volume>359</volume>
<fpage>1097</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="doi">10.1126/science.aat0835</pub-id>
<pub-id pub-id-type="pmid">29590026</pub-id>
</element-citation>
</ref>
<ref id="B165-jcm-07-00521">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Psychobiotics and the gut-brain axis: In the pursuit of happiness</article-title>
<source/>Neuropsychiatr Dis. Treat.
          <year>2015</year>
<volume>11</volume>
<fpage>715</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.2147/NDT.S61997</pub-id>
<pub-id pub-id-type="pmid">25834446</pub-id>
</element-citation>
</ref>
<ref id="B166-jcm-07-00521">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sawada</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fujiwara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rokutan</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Para-psychobiotic Lactobacillus gasseri CP2305 ameliorates stress-related symptoms and sleep quality</article-title>
<source/>J. Appl. Microbiol.
          <year>2017</year>
<volume>123</volume>
<fpage>1561</fpage>
<lpage>1570</lpage>
<pub-id pub-id-type="doi">10.1111/jam.13594</pub-id>
<pub-id pub-id-type="pmid">28948675</pub-id>
</element-citation>
</ref>
<ref id="B167-jcm-07-00521">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barichella</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pacchetti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bolliri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cassani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Iorio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pusani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pinelli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Privitera</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cesari</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Faierman</surname>
<given-names>S.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT</article-title>
<source/>Neurology
          <year>2016</year>
<volume>87</volume>
<fpage>1274</fpage>
<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000003127</pub-id>
<pub-id pub-id-type="pmid">27543643</pub-id>
</element-citation>
</ref>
<ref id="B168-jcm-07-00521">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamtaji</surname>
<given-names>O.R.</given-names>
</name>
<name>
<surname>Taghizadeh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Daneshvar Kakhaki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kouchaki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bahmani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Borzabadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Oryan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mafi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asemi</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial</article-title>
<source/>Clin. Nutr.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.clnu.2018.05.018</pub-id>
</element-citation>
</ref>
<ref id="B169-jcm-07-00521">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ticinesi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tana</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nouvenne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prati</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lauretani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Meschi</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Gut microbiota, cognitive frailty and dementia in older individuals: A systematic review</article-title>
<source/>Clin. Interv. Aging
          <year>2018</year>
<volume>13</volume>
<fpage>1497</fpage>
<lpage>1511</lpage>
<pub-id pub-id-type="doi">10.2147/CIA.S139163</pub-id>
<pub-id pub-id-type="pmid">30214170</pub-id>
</element-citation>
</ref>
<ref id="B170-jcm-07-00521">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agahi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hamidi</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Daneshvar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hamdieh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Soheili</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alinaghipour</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Esmaeili Taba</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Salami</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Does severity of Alzheimer’s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial</article-title>
<source/>Front. Neurol.
          <year>2018</year>
<volume>9</volume>
<fpage>662</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2018.00662</pub-id>
<pub-id pub-id-type="pmid">30158897</pub-id>
</element-citation>
</ref>
<ref id="B171-jcm-07-00521">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patusco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Role of probiotics in managing gastrointestinal dysfunction in children with autism spectrum disorder: An update for practitioners</article-title>
<source/>Adv. Nutr.
          <year>2018</year>
<volume>9</volume>
<fpage>637</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="doi">10.1093/advances/nmy031</pub-id>
<pub-id pub-id-type="pmid">30202938</pub-id>
</element-citation>
</ref>
<ref id="B172-jcm-07-00521">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudzki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ostrowska</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pawlak</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Małus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pawlak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Waszkiewicz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Szulc</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Probiotic <italic>Lactobacillus plantarum</italic> 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study</article-title>
<source/>Psychoneuroendocrinology
          <year>2018</year>
<volume>100</volume>
<fpage>213</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2018.10.010</pub-id>
<pub-id pub-id-type="pmid">30388595</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="jcm-07-00521-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>The bidirectional signaling within the GBA with the involvement of sterile inflammation of the brain and actions of microbiota and circulating adult stem cells. For details, see the text.</p>
</caption>
<graphic xlink:href="jcm-07-00521-g001"></graphic>
</fig>
<table-wrap id="jcm-07-00521-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">jcm-07-00521-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Microbiota and its metabolites alterations in various psychiatric conditions.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">The Disease</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Microbiota-Related Fingerprint</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Depression</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>↑ Bacteroidetes, Proteobacteria, Actinobacteria, Enterobacteriaceae, Alistipes,</italic> propionic, isobutyric, and isovaleric acids</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B60-jcm-07-00521">60</xref>,<xref ref-type="bibr" rid="B61-jcm-07-00521">61</xref>,<xref ref-type="bibr" rid="B62-jcm-07-00521">62</xref>,<xref ref-type="bibr" rid="B63-jcm-07-00521">63</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>↓ Faecalibacterium, Bifidobacterium, Lactobacillus</italic>; serotonin, noradrenalin, SCFAs, kynurenic acid, kynurenine</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>↑ Corinobacteriaceae, Prevotella, Succinivibrio, Collinsella, Megasphaera, Klebsiella, Methanobrevibacter, Clostridium</italic>
</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B64-jcm-07-00521">64</xref>,<xref ref-type="bibr" rid="B65-jcm-07-00521">65</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>↓ Blautia, Coprococcus, Roseburia,</italic>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bipolar disorder</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>↑ Bacteroides, Actinobacteria, Coriobacteria</italic>
</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B66-jcm-07-00521">66</xref>,<xref ref-type="bibr" rid="B67-jcm-07-00521">67</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>↓ Faecalibacterium, Roseburia, Alistipes,</italic>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Parkinson’s disease</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>↑ Bacteroides, Roseburia</italic>
</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B68-jcm-07-00521">68</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>↓ Blautia, Coprococcus, Dorea, Oscillospira, Akkermansia</italic>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Autism Spectrum Disorder</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>↑ Streptococcus, Clostridiales, Comamonadaceae, Akkermansia, Rhosococcus, Oscillospira, Desulvibrio, Burkholderia, Collinsella, Corynebacterium, Dorea, and Lactobacillus;</italic> acetic and propionic acid, p-cresol, Glutamate<italic>,</italic></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B69-jcm-07-00521">69</xref>,<xref ref-type="bibr" rid="B70-jcm-07-00521">70</xref>,<xref ref-type="bibr" rid="B71-jcm-07-00521">71</xref>,<xref ref-type="bibr" rid="B72-jcm-07-00521">72</xref>,<xref ref-type="bibr" rid="B73-jcm-07-00521">73</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>↓ Firmicutes, Faecalibacterium, Ruminococcus, Proteobacteria, Fuscobacteria, Verrumicrobia, Bifidobacterium, Neisseria, Alistipes, Bilophila, Dialister, Parabacteroides,</italic> and <italic>Veillonella,</italic> butyric acid, tryptophan, kynurenic acid,</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Attention-Deficit Hyperactivity Disorder</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>↑ Actinobacteria (Bifidobacterium</italic> genus<italic>)</italic></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B74-jcm-07-00521">74</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>↓ Firmicutes (Clostridiales</italic> order<italic>)</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Alzheimer’s disease</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>↑ Blautia, Phascolarctobacterium, Gemella, E.coli, Shigella, Ps. aueruginosa</italic>
</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B75-jcm-07-00521">75</xref>,<xref ref-type="bibr" rid="B76-jcm-07-00521">76</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>↓ Ruminococcaceae, Turicibacteraceae, Peptostreptococcaceae, Clostridiaceae, Mogibacteriaceae,</italic> and the genera <italic>SMB53 (</italic>family<italic>, Clostridiaceae) Dialister, Clostridium, Turicibacter,</italic> and cc115 (family <italic>Erysipelotrichaceae)</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Multiple sclerosis</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>↑ </italic>
<italic>Akkermansia muciniphila, Acinetobacter calcoaceticus</italic>
</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B77-jcm-07-00521">77</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>↓ </italic>
<italic>Parabacteroides distasonis</italic>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Anorexia nervosa</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>↑ </italic>
<italic>Methanobrevibacter smithii</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B78-jcm-07-00521">78</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="jcm-07-00521-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">jcm-07-00521-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Probiotics strains with documented efficacy in gut-brain axis disorders [<xref ref-type="bibr" rid="B144-jcm-07-00521">144</xref>,<xref ref-type="bibr" rid="B148-jcm-07-00521">148</xref>,<xref ref-type="bibr" rid="B166-jcm-07-00521">166</xref>,<xref ref-type="bibr" rid="B172-jcm-07-00521">172</xref>].</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Condition</td>
<td align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Strain</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Anxiety and depression</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>Lactobacillus fermentum</italic> NS8 and NS9, <italic>Lactobacillus casei</italic> Shirota, <italic>Lactobacillus gasseri</italic> OLL2809, <italic>Lactobacillus rhamnosus</italic> JB-1, <italic>Lactobacillus helveticus</italic> Rosell -52, <italic>Lactobacillus acidophilus</italic> W37, <italic>Lactobacillus brevis</italic> W63, <italic>Lactococcus lactis</italic> W19 and W58, <italic>Bifidobacterium longum</italic> Rosell-175, <italic>Bifidobacterium longum</italic> NCC3001, <italic>Bifidobacterium longum</italic> 1714, <italic>Bifidobacterium bifidum</italic> W23, <italic>Bifidobacterium lactis</italic> W52, <italic>Lactobacillus plantarum</italic> 299v</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stress</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>Lactobacillus casei</italic> Shirota, <italic>Lactobacillus helveticus</italic> Rosell -52, <italic>Lactobacillus plantarum</italic> PS128, <italic>Bifidobacterium longum</italic> Rosell-175, <italic>Lactobacillus gasseri</italic> CP230 *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">FGIDs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>Lactobacillus plantarum 299v</italic> (DSM 9843), <italic>Escherichia coli</italic> DSM17252, <italic>Bifidobacterium animalis</italic> DN-173, <italic>Saccharomyces boulardii</italic> CNCM I-745<break></break><italic>Bifidobacterium infantis</italic> 35624, <italic>Lactobacillus rhamnosus</italic> NCIMB 30174, <italic>Lactobacillus plantarum</italic> NCIMB 30173, <italic>Lactobacillus acidophilus</italic> NCIMB 30175, <italic>Enterococcus faecium</italic> NCIMB 30176</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>* Para-psychobiotic-heat inactivated strain.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>